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1 Introduction
1.1 Epithelial Cells
In vertebrates two of the major tissue types are epithelial- and connective tissue. They present
two extremes in which the structural roles played by the matrix and by cell-cell contacts are
different. In connective tissues extracellular matrix is plentiful and cells are sparsely distributed
within it. The matrix is rich in fibrous polymers, especially collagen (Loehr, 1996), and bears
most of the mechanical stress to which the tissue is subjected (Leonova and Raphael, 1997;
Mogensen et al., 1998). The cells are attached to components of the matrix but direct attachments
between these cells are relatively seldom. In epithelial tissues, by contrast, cells are tightly
bound together into sheets. Extracellular matrix is scanty and consists mainly of a thin mat
called the ”basal lamina”, which underlies the cellular sheet. Here the cells themselves, rather
than the matrix, bear most of the mechanical stresses by means of strong intracellular protein
filaments which transmit mechanical stress from one cell to the next. These filaments are
directly or indirectly attached to transmembrane proteins in the plasma membrane (Sato and
Kamiya, 2000), where specialized junctions are formed between the surface of adjacent cells
and with the underlying basal lamina (see Fig.1).
Epithelial cell sheets line all the cavities and inner surfaces of the body, and the specialized
junctions between the cells enable these sheets to form barriers to the movement of water,
solutes, and cells from one body component to another (Forslind, 1994; Leonova and Raphael,
1997). Epithelial sheets almost always rest on a supporting bed of connective tissue which
may attach them to other tissue (such as muscle) that do not themselves have either strictly
epithelial or strictly connective-tissue organization. Both compartments influence each other
not only during organogenesis but also in carcinogenesis (Condon and Bosland, 1999). It is
indisputable that carcinogenesis depends on mesenchymal factors (Mori and Miyazaki, 2000).
Epithelial structures are found in almost all organs which have developed from the ectoderm,
mesoderm, entoderm and are characterized by at least two different membrane areas exhibiting
different functions. Cells with functionally different membrane sides are called ”polar”. In
contrast to plant cells which are surrounded by a cell wall, animal cells have to maintain
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contrast to plant cells which are surrounded by a cell wall, animal cells have to maintain
tissue stability by developing close and durable connections with their neighboring cells,
these are the cell junctions (compare Fig.1).
Figure 1
Fig.1: Distribution of various cell-contacts between epithelial cells of the small intestine.
After: Molekulare Zellbiologie, de Gruyter 1996, by Harvey Lodish, Second Edition,  p 653
Cell junctions
Despite the many structural and biochemical differences among various types of epithelia, all
have at least one important function in common: they serve as selective permeability barriers,
separating fluids on each side having different chemical compositions.
Tight junctions
Tight junctions play two distinct roles in this selective barrier function (Alberts et al., 1994).
The epithelial cells lining the small intestine keep most of the gut contents in the lumen. At
the same time, however, the cells must transport selected nutrients across the cell sheet from
the lumen to the extracellular fluid permeating the connective tissue on the other side, from
microvillus
Tight-junction
Adherence-junction
(Adherence belt)
Desmosome
Gap-junction
Intermediate filaments
Hemidesmosome
Basal lamina
apical surface
lateral surfae
basal surface
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the lumen to the extracellular fluid permeating the connective tissue on the other side, from
where the nutrients diffuse into small blood vessels. This transcellular transport requires two
sets of membrane-bound carrier proteins: one is confined to the apical surface (facing towards
the lumen; covered with microvilli to enlarge the surface) of the epithelial cell and transports
molecules from the lumen of the gut into the cell; the other, which is confined to the
basolateral (basal and lateral) surfaces allows the same molecules to leave the cell by facilitated
diffusion into the extracellular fluid on the other side. As this directional transport is to be
maintained, the carriers must not be allowed to migrate between the apical and basolateral
membranes. Furthermore, the spaces between epithelial cells must be sealed to prevent already
transported molecules from diffusing back into the lumen of the gut. Tight junctions between
the epithelial cell block these kinds of diffusion.
The molecular structure of tight junctions is still uncertain although major structural molecules
like ZO-1, occludin or symplekin have been identified (Chen et al., 2000).
Anchoring junctions
Anchoring junctions enable epithelial cells to function as robust structural units by connecting
the cyctoskeletal elements of a cell either to those of another cell or to the extracellular
matrix (compare Fig. 1). They occur in three structurally and functionally different forms:
adherence junctions, desmosomes and hemidesmosomes.
E-cadherin and β-catenin are the most important molecules in adherence junctions which are
the first junctions observed when dissociated cells were allowed to re-associate (Lincz et al.,
1997). Cadherins are responsible for Ca2+-dependent cell-cell adhesion. Virtually all vertebrate
cells express one or more cadherins, each encoded by a separate gene, the particular set
expressed being characteristic of the cell type. In vitro, the removal of extracellular calcium
or treatment with an cadherin-blocking antibody disrupts the tissue, and if cadherin-mediated
cell-adhesion is left intact, antibodies against other adhesion molecules are without effect.
Under in vivo conditions, mutations which inactivate the function of cadherins cause embryos
to fall apart early in development or prevent organ development. Cadherins mediate cell-cell
adhesion by a homophilic mechanism (compare Fig. 2). In tumors the loss of E-cadherin
mediated cell-cell adhesion is a critical step towards metastasis (Perl et al., 1998). The
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mediated cell-cell adhesion is a critical step towards metastasis (Perl et al., 1998). The
cytosolic partners of E-cadherin in epithelial cells connecting the transmembrane-domain of
E-cadherin with the actin-filaments of neighboring cells are the catenins, in particular α-, β-
γ-catenin as well the protein pp120 (compare Fig. 2).β-catenin is of particular interest with
respect to its additional function as transcription factor. Cytosolic β-catenin normally is
degraded in a complex including the APC-gene product and the glycogen-sythase-kinase-3-β
(GSK3β). In the case of a mutated APC-gene being often found associated with colorectal
cancer (Gryfe et al., 1997), degradation is not taking place facilitating the transport of β-catenin
into the nucleus of cells and the initiation of transcription of oncogenes like c-myc (Eberhart
et al., 2000; Sparks et al., 1998).
Figure 2: Roles of cadherins and catenins in cell-cell contacts
Fig.2: The roles of cadherins and catenins in cell-cell contact and transcription. From Clontechniques 03/99
In contrast to adherence junctions in cell-cell contact, adhesions between the cell and the
matrix exists in so called ”focal adhesions” comprising of integrins as cell-surface matrix
receptors and a cytosolic complex consisting of attachment proteins like talin, α-actinin and
vinculin (Burridge et al., 1988) but also paxillin and the focal adhesion kinase (FAK) (Tremblay
et al., 1996).
Desmosomes and hemidesmosomes act as rivets to distribute tensile or shearing forces through
an epithelium. Desmosomes are button-like proteins of intercellular contact. On the cytosolic
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an epithelium. Desmosomes are button-like proteins of intercellular contact. On the cytosolic
surface of each interacting plasma membrane is a dense plaque composed of proteins like
plakoglobin or desmoplakin. These plaques are connected to the actin-filaments of their cells
and by transmembrane linker proteins (members of the cadherin-family) to the cytoplasmic
plaque of the neighboring cell (Buxton and Magee, 1992).
In hemidesomsomes the transmembrane linker proteins belong to the integrin-family used in
focal adhesions rather than to the cadherin family used in desmosomes (Schwarz et al., 1990).
Gap junctions
Gap junctions are the most wide spread junctions shared by practically all animal species.
Gap junctions allow direct communication and exchange of small molecules like ions, sugars,
amino acids, nucleotides between cells while macromolecules are held back. Gap junctions
couple cells chemically and electrically. They consist of proteins called connexins which
form transmembranous channels. These channels are closed at a low pH or a high Ca2+-
concentration and open at a high pH or low Ca2+-concentration (Bennett and Verselis, 1992).
Cell adhesion in human cancer is a critical point. Upon malignant transformation epithelial
cells dramatically render their biological properties. To metastasize a cell of a typical solid
tumor must be able to loose the adhesion to its original neighbors, escape from the tissue of
origin, burrow through other tissues until they reach a blood- or lymphatic vessel, cross the
basal lamina and endothelial lining of the vessel so as to enter the circulation, exit from the
circulation elsewhere in the body, survive and proliferate in a new environment (Fidler,
1991). The loss of E-cadherin has been described to be associated with invasion and metastasis
(Perl et al., 1998; Takeichi, 1993).
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1.2 Morphology  and physiology of the human pancreas
The pancreas is the largest secreting gland in the human body and consists of the endocrine
and the exocrine system. Morphologically it is divided into five areas: uncinate process, head,
neck, body and tail (compare Fig. 3). The endocrine system secretes its products directly into
the blood. The responsible cell types are organized in the islets of Langerhans. These islets of
Langerhans are ovoid, 76 x 175 µm collections of cells scattered throughout the pancreas
(compare Fig. 4 and 5). They make up about 2% of the volume of pancreas. In human, there
are 1-2 million islets and the cells in the islets can be divided into different types on the basis
of their staining and morphology. There are at least 4 distinct types of cells (alpha, beta, delta
and gamma) in human pancreatic islets. Alpha cells: about 20% of total islet cells, secrete
glucagon. Beta cells: most abundant (60-75%), locate in the center of each islet, secrete
insulin. Delta cells: secrete somatostatin. Less common, gamma cells: secrete pancreatic
polypeptide.
Fig. 3: Structure of the human pancreas (schematic) uncinate process: The part of the gland that bends
backwards and underneath the body of the pancreas. Two very important blood vessels, the superior mesenteric
artery and vein cross in front of the uncinate process. Head: The widest part of the gland. It is found in the right
part of abdomen, nestled in the curve of the duodenum which forms an impression in the side of the gland.
Neck: The thin section between the head and the body of the gland. Body: the middle part of gland between the
neck and the tail. The superior mesenteric blood vessels run behind this part of the gland. Tail: the thin tip of
gland in the left part of abdomen in close proximity with the spleen. This figure was taken from: Chapter 65
”Functions of the Pancreas” in R. Greger and U. Windhorst (eds).
Figure 3
B=	body
H=	head
N=	neck
T= tail
Un=	uncinate
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Fig. 4: Structure of the human pancreas: Schematic cross-section through the body as indicated in panel a. The
exocrine compartment consisting of globular acini (enlarged in panel c) is connected to the main pancreatic duct
by ”Schaltstücke”, intra- and interlobular ducts and secretes pancreatic enzymes or pre-forms related to the
digestive process like: α-Amylase, Lipase, Trypsinogen 1, 2, 3,  Chymotrypsin and others into the main
pancreatic duct. The endocrine compartment organized in the islets of Langerhans (enlarged in panel d) consists
of four specialized cell types: alpha, beta, delta and gamma cells which secrete insulin, glucagon, somatostatin
and pancreas polypeptide into blood vessels. This figure was taken from: Chapter 65 ”Functions of the Pancreas”
in R. Greger and U. Windhorst (eds)
The exocrine pancreas is a secreting gland and characterized by the combination of ductal
and acinar cells. The acinar unit of the pancreas is comprised of a group of acinar cells
representing a three-dimensional goblet surrounding the acinar lumen (compare Fig. 2, panel
c). Ultrastructurally these cells contain extensive Golgi apparatuses and numerous secretory
granules containing zymogen components near their apical membranes. Acinar cells secrete
enzymes which are related to digestive processes. The most important ones are: Amylase,
Lipase, Trypsin and Chymotrypsin. Except Amylase and Lipase these enzymes are secreted
as pre-forms being either activated by enterokinases or acids of the bile duct. The pancreatic
ductal system connects secretory cells of the exocrine pancreas to the duodenum. Ducts arise
at the acinar unit of the pancreas and function by adding secretions finalizing the composition
of the pancreatic juice (mainly bicarbonate-rich fluid) and facilitate the transport of secretions
Figure 4
a
b
c
d
Cross-section of
the pancreas
Acinar cells secrete pancreatic
enzymes into the pancreatic duct
Islets of Langerhan cells secrete
hormones into blood vessels
Exocrine (out)
Endocrine (in)
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of the pancreatic juice (mainly bicarbonate-rich fluid) and facilitate the transport of secretions
of the acinar cells to the duodenum where they are needed to digest carbohydrates, proteins
and fat. Approximately 1.5 l of pancreatic juice is produced per day. These intralobular duct
cells also express glycoproteins of the mucin-family like MUC-1 (Monges et al., 1999). Near
the junction of the acinus the centroacinar cell is located, whose nature remains unclear. It is
claimed to represent a distinct cell type while others argue it is either a ductal or an acinar
cell.
The morphology of the ductal cells change in moving away from the acinar unit towards the
duodenum. The cells generally become taller when approaching the stage of interlobular
ducts. The whole ductal compartment containing all cells from the smallest intra-, interlobular,
and intercalating ducts to the ductus pancreaticus present proximately 5% of the total mass of
the pancreas (Lohr and Friess, 1996). The vast majority of this tissue, nearly 80% (Githens,
1988) consists of acinar cells (compare Fig. 5).
Figure 5
Fig. 5: Structure of the human pancreas: Cross-section through the body of a human pancreas. All  functional
components of the pancreas are visible in this figure. The islets of Langerhans containing the endocrine cells of
the pancreas are indicated with the red arrow. Acini display the major component of pancreatic tissue filling
80% of this image being connected by a loose fibrous structure containing the thin vessels nutrifying the acini.
The right half of the image shows a pancreatic duct (green arrow) cut crossways surrounded by a periductal
fibre zone (blue arrow).
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1.3 Pancreatic carcinoma
Pancreatic carcinoma belongs to the frequent causes of death caused by malignant disease in
western Europe and is placed on the fifth position of U.S cancer statistics.
Most patients suffering from a pancreatic carcinoma are diagnosed in advanced stages of this
disease when metastasis are frequently observed. A high number of these patients are classified
as inresectable and have a very poor prognosis. Radiochemotherapy and other therapies
failed, the five-year survival rate varies between 0.4% and 2% worldwide (Murr et al., 1994;
Takeda et al., 1998). In contrast to colorectal carcinoma where a pre-screening is possible
with the ”hemocult-test”, no such systems are available for an early diagnosis of pancreatic
carcinoma. With increasing age the incidence of the pancreatic carcinoma rises continuously.
Pre-dispositions are factors like smoking, fat-enriched nutrition and alcohol-induced chronic
pancreatitis (Chari et al., 1996; Gates, 2000; Hart, 1999; Mangray and King, 1998; Tominaga
and Kuroishi, 1998). The chronic pancreatitis as a pre-disposing event is critically discussed
although a publication from Lowenfels and co-workers give some evidence (Lowenfels et al.,
1993). Model systems to address pre-malignant lesions in pancreatic carcinoma or early steps
in the carcinogenesis are highly desired. Attempts to establish cell lines from primary duct
cells are difficult and have not led to the expected success so far (Jesnowski et al., 1998).
Further uncertainty has been caused by reports about transdifferentiation of former acinar
cells into cells exhibiting ductal characteristics (Schmid et al., 1999).  These observations
cause difficulties to construct a suitable model system for the investigation of early pancreatic
cancer. The scenario becomes even more complicated if one considers the role of the
mesenchymal compartment during carcinogenesis which is also of major importance for the
proper development of the pancreas during embryogenesis and reveals its importance in
carcinogenesis by the fibrosis observed in pancreatic carcinoma (Lohr et al., 1999; Sparmann
et al., 1997).
Suspecting the metabolically hyperactive acinar cell to be the germinal cell in many cancers,
acinar cell carcinomas represent an extremely small percentage of pancreatic cancers as well
as neuroendocrine cells from the islets of Langerhans (Mangray and King, 1998). The
vastmajority (90%) is classified as ductal adenocarcinomas (Cubilla and Fitzgerald, 1975;
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vastmajority (90%) is classified as ductal adenocarcinomas (Cubilla and Fitzgerald, 1975;
Kloppel et al., 1980; Kozuka et al., 1979). A characteristic feature of ductal adenocarcinomas
is their localization in the head of the pancreas accompanied by a massive proliferation of
stroma cells (desmoplasia) with an infiltration of well differentiated duct-like structures.
Desmoplastic tissue contains fibroblasts as the major cellular compartment connected with
proteins of the extracellular matrix (ECM) as the non-cellular compartment (Loehr, 1996).
This noticeable desmoplasia of pancreatic adenocarcinoma is shared with carcinomas of the
prostate gland and mammary gland also arising from epithelial cells of the corresponding
organ (Loehr, 1996). The influence of the mesenchymal compartment is critical for proliferation,
secretion and differentiation of pancreatic epithelial cells (Hahn et al., 1987; Stallmach et al.,
1991). Subsequently the components - epithelial cell and stroma (including ECM)  are classified
as a functional unit influencing each other during development, inflammation or carcinogenesis.
Carcinogenesis as a ”multi-step-event” by means of a step-wise accumulation of genetic
alterations leading to an instable malignant genotype has been shown for colorectal carcinoma
(Fearon and Vogelstein, 1990).
Lacking model systems for the detection of early lesions during pancreatic carcinoma and the
difficulty  to obtain and isolate primary pancreatic duct cells or highly differentiated pancreatic
tumor cells from early stages of pancreatic carcinoma make it difficult to define such a
multi-step-carcinogenesis for the pancreatic carcinoma.
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1.3.1 Pancreatic carcinoma: Molecular basis
Due to the ductal origin of the vast majority of pancreatic adenocarcinomas, pancreatic
cancer cells express several ductal marker antigens like the carbonic anhydrase type II (CAII)
(Nishimori et al., 1999), cytokeratines CK7, CK8, CK18, CK19 (Bouwens et al., 1994;
Schussler et al., 1992), the Carcinoembryonic antigen CEA (Kim et al., 1990) and the Cystic
Fibrosis Transmembrane Conductance Regulator (CFTR) (Hollande et al., 1998). Ductal cells
are negative for Amylase and Lipase and can be discriminated from acinar cells which are
positive, by immunocytochemical staining for these two antigens.
The development of neoplasia is coupled with a dysregulation of important cellular processes
like the programmed cell death (apoptosis), proliferation, differentiation of cells and cell
adhesion (Goss and Groden, 2000; Nollau et al., 1997). The genetic background of these
dysregulations has been shown in  experiments where human tumor DNA was transfected
into several cell types and induced a neoplastic transformation (Andersen et al., 1981; Jhappan
et al., 1990; Krontiris and Cooper, 1981; Perucho et al., 1981). Experimental results from
other tumors like the colorectal carcinomas led to the discovery of several oncogenes or
tumorsuppressor genes involved in the development of sporadic pancreatic carcinoma. Recent
developments in molecular biology helped to extent the knowledge about new oncogenes and
tumorsuppressor genes during the past few years.
The most frequent and best characterized genetic alterations in human pancreatic carcinoma
affect the Ki-ras protooncogene (74-100%), p16ink4 (up to 98%), p53 (43-76%) and DPC4
(53%). See table 1 for more summarized details and references.
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Table 1: Most frequent genetic alterations in pancreatic carcinoma
After: Pancreatic Cancer; Molecular and Clinical Advances by J.P. Neoptolemos and N.R. Lemoine; Blackwell
Science 1996, pages 119-121. (n.d = not determined)
1.3.2 Oncogenes
Ki-ras
Ras oncogenes were first recognized as the transforming genes of Harvey and Kirsten murine
sarcoma viruses (Ha-MSV, Ki-MSV). These highly oncogenic retroviruses were generated
during passage of murine leukemia viruses through laboratory strains of rats (Harvey, 1964;
Kirsten and Mayer, 1967). Subsequent molecular analyses showed that Ha-MSV and Ki-MSV
contained sequences in their genomes that were not present in the genomes of the parental
viruses; these newly acquired sequences appeared to be the result of viral transduction of
cellular genes and were thus likely to be responsible for oncogenic transformation. This was
confirmed when it was shown that subgenomic fragments of Ha-MSV containing only cell-
derived sequences were able to transform cells. The ras oncogene family consists of three
human genes: Ki-ras, Ha-ras and N-ras. They represent the most frequently mutated dominant
Gene Chromosomal
localization
Alteration Frequency Reference
Ki-ras
p53
p16
DPC4
BRCA2
Rb1
12p13
17p13
9p21
18q21
13q14
point mutations codon
12,13,61
point mutation exons
5, 6, 7, 8; LOH
homozygous deletion, point
mutation, hypermethylation
homozygous deletion, point
mutation, LOH
LOH
LOH, point mutation
74-100%
43-76%
27-98%
50%
DCC LOH18q21
27%
0-10%
Dergham et al., 1997
Rozenblum et al.,1997
Dergham et al., 1997
Rozenblum et al., 1997
Redstone et al.,1994
Rozenblum et al., 1997
Huang et al., 1996
Caldas et al., 1994
Hahn et al., 1996 
Rozenblum et al., 1997
Simone et al., 1994
Hohne et al., 1992
Barton et al., 1995
Goggins et al.,  1997 
Schutte et al., 1997
Barton et al., 1995
Huang et al., 1996
n.d
13q12.3
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human genes: Ki-ras, Ha-ras and N-ras. They represent the most frequently mutated dominant
oncogenes in human neoplasia (Bos, 1989). The gene products are small GTP-binding proteins
localized at the inner cell membrane, having a molecular weight of 21kDa (p21). Ras proteins
play a role in the signal transduction of receptor tyrosin-kinases like the EGF-receptor as well
as  they are further involved in processes like cellular differentiation, cell cycle progression
and secretion (Bollag and McCormick, 1991). Ras-proteins are activated by the binding of
GTP. The intrinsic GTPase hydrolyzes GTP into GDP and monophosphate. After that,  ras-
proteins return into the inactive form facilitated by GTPase-activating proteins (GAPs). Point
mutations in the Ki-ras gene lead to a constitutive activation of the ras-signaling cascade by
inhibiting the hydrolysis of GTP. Further the ras oncogene product p21ras requires farnesylation
for its transforming activity. This key post-translational modification is catalyzed by p21ras
farnesyltransferase, which transfers farnesyl from farnesylpyrophosphate to the cysteine of
the CA1A2X carboxyl-terminal tetrapeptide of p21ras. Inhibitors of farnesyltransferases were
therefore thought to display potential therapeutic agents. (Prendergast, 2000; Reuter et al.,
2000)
1.3.3 Tumor suppressor genes
Tumor suppressor genes mostly function to inhibit the cell growth and cell cycle; they act to
prevent the development of neoplasia. Mutations in tumor suppressor genes cause the cell to
ignore one or more of the components of the network of inhibitory signals, removing the
brakes from the cell cycle and resulting in a higher rate of uncontrolled growth -- cancer.
p53
The p53 protein blocks cells from passing beyond G1 in the cell cycle by binding to a
transcription factor called E2F (Vaishnav and Pant, 1999). This prevents E2F from binding to
the promoters of proto-oncogenes such as c-myc and c-fos. Transcription of c-myc and c-fos
is needed for mitosis so blocking the transcription factor needed to turn on these genes
prevents cell division. Normally, damage to cellular DNA initiates increased expression of
p53 which leads to arrest of the cell cycle. This interruption permits DNA-repair to occur
before the cell resumes the cell cycle and normal proliferation. If repair of the DNA is not
Introduction                                                                                                        18
before the cell resumes the cell cycle and normal proliferation. If repair of the DNA is not
successful, the cell undergoes apoptosis, programmed cell death. When p53 mutates, damaged
cells are not arrested in G1 and DNA-repair does not take place. This failure to arrest
DNA-damaged cells will be repeated in subsequent cell cycles permitting other mutations to
accumulate culminating in neoplastic transformation, tumor formation and cancer (Geske et
al., 2000; Wang and Harris, 1997).  Point mutations and deletion of the chromosomal locus of
p53 on chromosome 17p are the most abundant alterations in human malignancies (Hollstein
et al., 1991; Kalthoff et al., 1993; Levine, 1992).
Mutations in the p53 gene result in abnormal proteins exhibiting an extended half-life and
therefore being more stable than wild-type p53. Observations indicate that a normal p53 gene
is dispensable for embryonic development, but that its absence predisposes animals to neoplastic
disease (Donehower et al., 1992).
p16
The p16 tumor suppressor gene is thought to play an important role in cell cycle regulation
by encoding for protein products being able to inhibit the progression from G1 to S phase in
the cell cycle. Recently, the p16 gene has been found to be mutated or deleted in a variety of
different types of primary human malignant tumors and human-derived malignant tumor cell
lines. p16 is localized on chromosome 9p21 and was identified as the first member of the
INK4-family of cyclin-dependent-kinases (cdk). During the cell cycle cells have to pass a
restriction point which decides if the cell ”is allowed” to proceed into the S-phase of the cell
cycle when the genetic material is doubled. For the progression of the G1-phase activation of
cyclin D1 by cdk4 is required. The complex of cyclin D1/cdk4 phoshorylates the retinoblastoma
gene product Rb. This phosphorylation prevents the binding of Rb to the transcription factor
E2F. Unbound E2F now acts as transcription factor and leads to progression into the S-phase
of the cell cycle. p16 inhibits G1/S-progresssion by inactivating the cdk4/cyclinD1-complex.
This prevents phosphorylation of Rb and therefore G1/S-progression. Loss of p16 activity
turns off the inhibitory effect at the cdk4/cyclinD1 level and leads to an increased cell cycle
progression. Up to 98% of pancreatic carcinoma show inactivation of p16 by either homozygous
deletion in both alleles or a mutation in one and deletion of the other allele (Caldas et al.,
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deletion in both alleles or a mutation in one and deletion of the other allele (Caldas et al.,
1994; Huang et al., 1996; Naumann et al., 1996). Patients in which pancreatic carcinoma was
associated with inherited melanoma, beared p16-mutations in the germ line (Hussussian et
al., 1994; Kamb et al., 1994).
DPC4 (Smad4)
The DPC4-gene is localized on chromosome 18q21.1. High sequence similarities of the
human exons 1, 2 and 11 to the Mad-protein (Mother against decapentaplegic) of Drosophila
melanogaster and the sma-2, sma-3 and sma-4 proteins of Caenorhabdites elegans are reported
(Liu et al., 1996). These proteins display a part of the signal-transduction pathway of TGF-β.
Therefore a role of the DPC4 gene product, relying  on the sequence similarities, in the
TGF-β pathway  is hypothesized. TGF-β signaling is mediated by phosphorylation of Smad2
and Smad3 followed by complex-formation with Smad4. Smad-proteins mediate or resemble
the TGF-β signaling pathway which is initiated by ligands of the TGF-β-superfamily including
TGF-β, Activin and BMP´s (bone morphogenic proteins). While TGF-β is known as a negative
regulator of the cell cycle (Adnane et al., 1998; Alexandrow and Moses, 1997), inactivation
of such regulation pathways by loss of DPC4 is likely. 90% of the analyzed pancreatic
carcinoma showed an allelic loss on chromosome 18q whereas 30% exhibited a homozygous
deletion of the locus 18q21.1 (Hahn et al., 1996; Hahn et al., 1996). In other tumors like
colorectal carcinoma and breast cancer, the frequency of DPC4 deletion was approximately
10% (Moskaluk et al., 1997; Schutte et al., 1996; Takagi et al., 1996). Interestingly a correlation
between inactivation of DPC4 and p16 was reported  (Rozenblum et al., 1997). In all investigated
cases inactivation of DPC4 coincided with p16-inactivation but not vice versa supporting the
idea that loss of p16-activity provides a selective advantage for the development of DPC4
mutations (Rozenblum et al., 1997). Next to the described genetic alterations there are some
less frequent mutations known.
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DCC
The DCC-gene consists of 29 exons overspanning 1.4 mega basepairs in direct vicinity to the
DPC4-gene localized on chromosome 18q. Recent works suggested genetic alterations in the
DCC-gene in pancreatic carcinoma (Hohne et al., 1992; Simon et al., 1994). Later data
showed that the  complete suppression of  the DCC expression is a rare event as well as a
deletion of the DCC locus (Barton et al., 1995). Due to the enormous size of this gene no
sequence analysis was performed in pancreatic carcinoma so far.
BRCA2
It is estimated that about 5-10% of breast cancer cases may be due to inherited predisposition.
Until now, two main susceptibility genes have been identified: BRCA1 and BRCA2 (Osorio
et al., 2000). A significant number of these family members developed pancreatic carcinoma
(Teng et al., 1996). In patients apparently developing sporadic pancreatic carcinomas, germ
line mutations in the BRCA2-gene were identified (Goggins et al., 1996). 27% of all analyzed
cases showed a LOH  (loss of heterozygosity) in tumors.  In 10% of these cases abnormalities
in the second allele were detected mainly identified as germ line mutations.
Rb1
Genetic alterations in the retinoblastoma gene 1 localized on chromosome 13q14 were detected
in less than 10% in the investigated pancreatic carcinomas (Barton et al., 1995; Huang et al.,
1996b). Tumors with point mutations in the p16-gene generally show no coexisting Rb1-
mutation which would moderate the effects of a loss of p16 activity.  Since p16-mutations are
frequent
events in pancreatic carcinoma, Rb1-mutations are rather infrequent (Schutte et al., 1997).
1.3.4 Chromosomal abnormalities in pancreatic carcinoma
Beside the described mutations in single genes chromosomal abnormalities, changing the
whole structure of the genome are observed in pancreatic carcinoma (Bardi et al., 1993;
Griffin et al., 1994; Griffin et al., 1995). Investigations on metaphase chromosomes discovered
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Griffin et al., 1994; Griffin et al., 1995). Investigations on metaphase chromosomes discovered
additive alterations on chromosome 7 and 20 as well as loss of the chromosome arms 1p and
6q to be decisive for pathogenesis of pancreatic carcinoma. Extensive studies on 17 pancreatic
carcinomas showed frequent allelic losses for the chromosome arms 1p (50%), 6p (50%), 6q
(50%), 8p (56%), 9q (96%), 10p (50%), 10q (50%), 12p (50%), 17p (95%), 18q (88%), 21q
(61%) and 22q (61%) (Lumadue et al., 1995). These data correlate with the chromosomal loci
of several tumor suppressor gene like p53 (17p) , DPC4 (18q) and p16 (9p).
1.3.5 Growth factors and cytokines
The genetic profile of pancreatic carcinoma consists not only of the described scopes like
inactivation of tumor suppressor gene, activation of oncogenes and protooncogenes or
chromosomal aberrations. It is further characterized by altered signal transduction pathways
of cytokines and growth factors and their corresponding receptors (Friess et al., 1999; Ketterer
et al., 1998). Overexpression of growth factors provide an advantage for tumor cells mostly
resulting in an increased proliferation rate. These growth factors like transforming growth
factor alpha (TGF-α), epidermal growth factor (EGF) and its receptor, acidic and basic
fibroblast growth factors (aFGF, bFGF) have influence on the autocrine growth regulation of
tumor cells (Korc et al., 1992; Yamanaka et al., 1993). Beside the autocrine growth stimulation
of tumor cells, growth factors  like TGF-β which is expressed in many pancreatic carcinoma
cells, support the proliferation of mesenchymal cells like fibroblasts in a paracrine manner
leading to the massive increase in the mesenchymal cells  associated with pancreatic carcinoma
called desmoplasia (Ellenrieder et al., 2000; Kalthoff et al., 1991). Since it is known that
overexpression of growth factors and their receptors is not restricted to pancreatic carcinoma
being also found in chronic pancreatitis, it is likely that only the combination of overexpression
and the described genetic defects leads to carcinogenesis.
Increasing knowledge of the molecular mechanisms in pancreatic carcinoma made molecular
biological techniques interesting for diagnosis and therapy. Identification of new genes
associated with early events in pancreatic carcinoma and the development of suitable model
systems resembling precursor-lesions should be the aims of on-going research.
Although tumors of different patients differ genetically, most of them share mutations in
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Although tumors of different patients differ genetically, most of them share mutations in
Ki-ras, p53 and p16 which are of pathological importance in most carcinomas. Especially  the
frequent activations of a ras-oncogene (Kalthoff et al., 1993b) in combination with mutations
of a tumor suppressor gene, in particular p16 (Naka et al., 1998), are likely to contribute to
the malignant phenotype of pancreatic adenocarcinomas. Model systems are required not
only to detect new genetic alterations but for helping to unravel the process of progression
from a pre-lesion towards a pancreatic carcinoma.
1.4 Therapeutic options
At the time of diagnosis nearly 90% of the patients have infiltrated lymph nodes and 80%
show metastasis in the liver. Over the last ten years, resection rates have increased from less
than 3% to over 10% in many published series and during the same period, operative mortality
has fallen from 25% to less than 10% (Cameron et al., 1993; Russell, 1990; Trede et al.,
1990). Despite these improvements in surgical technique, the five-year survival rates in these
same series ranged from 11 to 24% and few, if any, patients were actually cured of their
disease (Gudjonsson, 1987). Epidemological studies paint an even bleaker picture. Bramhall
et al. (1995) reported on a series of 13,560 patients with pancreatic cancer in whom only
2.6% underwent resection with a five-year survival of 5.5% and an overall five-year survival
of 0.2% (Bramhall et al., 1995).
The belief that surgery alone has had a major impact on long-term survival in pancreatic
cancer is overoptimistic. Although it may have had a marginal impact on improving five-year
survival, the most important determinants remain disease stage (Baumel et al., 1994; Cameron
et al., 1991; Funovics et al., 1989; Trede et al., 1990). Next to surgical treatment of pancreatic
cancer, other strategies have been applied like radiotherapy, chemotherapy or combinations
either used  as single methods or in adjuvant therapy. However, the results are still disappointing
(Andre and Balosso, 1999; Huguier and Mason, 1999; Kornek et al., 2000). A combination of
radical surgery and combined modality adjuvant therapy may improve the five year survival
to 20% or more (Douglass, 1987). Other forms of putative therapies are discussed and
strategies for genetic interventions are formulated (Takeda et al., 1998).
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There are five broad approaches to genetic intervention for cancer therapy and each has its
own advantage and drawbacks for clinical application.
1) Replacement or augmentation of tumor-suppressor gene function.
Possible candidate-genes are the p53- (Baker et al., 1990) or p16INK-gene (Serrano et al.,
1995).
2) Blockade of dominant gene expression.
Most experimental settings concerning this idea of therapy have made use of antisense
oligonucleotides or ribozymes to interrupt male-function of target-genes like p53, p16, DPC4
(Georges et al., 1993; Mukhopadhyay and Roth, 1993; Mukhopadhyay et al., 1991).
3) Genetically directed enzyme producing therapy  (GDEPT).
The principle of GDEPT is to take advantage of transcriptional differences between normal
and tumor cells, or between one tissue and the rest of the individual. Expression of a gene
encoding a prodrug-activating enzyme is directed by a tumor- or tissue-specific gene promotor
so that only these cells should become susceptible to the toxic effects of the prodrug when it
is subsequently administered systemically. Most studies have been done with the deaminase
gene and the herpes simplex virus thymidine kinase (HSV-tk) gene (Howard et al., 2000;
Howard et al., 1999).
4) Genetic immodulation.
Downregulation of HLA-system components is a widely observed phenomenon in various
common tumor types (Cabrera et al., 1992). Local expression or delivery by e.g. virus-based
systems of exogenous cytokines at the side of a tumor can elicit impressive anti-tumor
responses (Provinciali et al., 1994; Lopez et al., 1992).
5) Polynucleotide- and Peptide-vaccination
Inoculation of experimental animals with plasmids encoding a variety of proteins has been
shown to stimulate both antibody and T-cell immune responses which are specific and sometimes
long-lived. The tumor-associated antigen, CEA, for example has been utilized for active
adoptive immunotherapy. Early reports from Curiel et al. showed that intramuscular injection
of a plasmid expressing the human CEA complementary DNA could stimulate a humoral
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of a plasmid expressing the human CEA complementary DNA could stimulate a humoral
response against CEA in mice (Conry et al., 1994). The same group has since demonstrated
this approach can produce immunoprotection against tumor challenge with CEA-expressing
colon carcinoma cells (Conry et al., 1995). For peptide-vaccination studies with ras-proteins
have been set up. However, gene-therapeutic approaches are only useful in stages of disease
where only one gene-defect rather than a multi gene-defect is present or if the time course of
the major events in malignant transformation is known. So far surgery seems to be the only
therapy with curative chances in pancreatic cancer but hope is present based on new insights
in the molecular mechanisms underlying this disease. Earlier diagnosis together with the
knowledge of early genetic alterations and their appearance in the time course of pancreatic
cancer are a prerequisite for successful treatment approaches either based on surgery or
gene-therapy. Therefore defined model systems are required enable to:
1) Discover the early  genetic changes in pancreatic carcinoma.
2) Resemble normal duct epithelial cells helping us to gain an impression of what ”normal”
means and to set up a ”multi-step-carcinogenesis” model by step-wise introducing
putative transforming candidate genes into these cells  and monitoring their transforming
effects on ”normal” cells.
3) Integrate the mesenchymal compartment into the scenario of pancreatic cancer as a
long-time underestimated component in the development of this disease.
1.5 Experimental models in pancreatic cancer
1.5.1 In vivo models 
In vivo models are primarily  based on animal experiments and although not part of this work,
it should be mentioned they are important for the understanding of the complex situation
found in patients. However, more and more options arise to transfer in vivo-experiments to
the in vitro-level.
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Chemically induced cancers
Pancreatic cancer has been experimentally induced in rodents with at least 20 different
chemical carcinogens. Most of these chemicals are known mutagens which seem to act as
initiators of carcinogenesis by damaging DNA. Nitrosamines used in hamsters induce pancreatic
carcinoma with a ductal phenotype, remarkably similar to the human clinical situation in
morphological and molecular features (Birt et al., 1981). Recent studies on the effects of
castration, testosterone replacement and estrogen treatment of tumor foci in male rat, indicate
that testosterone promotes and estrogen inhibit, the growth of preneoplastic lesions in the
pancreas. This is of relevance to human pancreatic cancer since the male to female ratio of
2:1 in pancreatic cancer incidence might be related to the long term effects of sex steroid
hormones (Longnecker and Sumi, 1990). Although these data suggest a role for hormonal
treatment of pancreatic cancer (Bourhis et al., 1987; Greenway, 1987) most studies using
hormones had no positive effect so far.
Xenotransplantation models
Various different models have been described either using established cell lines for inoculation
in mice, hamster or rat or pieces of an original tumor. Primarily these transplantations were
carried out by subcutaneous inoculation. Recent publications showed that orthotopic transplants
behave different and must be considered to reflect the patients situation better than subcutaneous
transplants (Cui et al., 1998). Future perspectives in this field are ”humanized” mouse models
combining human tumor cells with human mesenchymal or human endothelial cells in a
mouse which e.g. expresses human MHC. These model systems will be even closer to the
patients situation.
Transgenic models
The introduction of genes into the germ line of mammals is a technology which offers
exciting possibilities for generating precise animal models of human diseases and for
understanding carcinogenesis. Since the development of embryonic stem cell technology in
the early 1980s and the generation of the first knockout mice about a decade ago, an explosive
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the early 1980s and the generation of the first knockout mice about a decade ago, an explosive
growth in the number of targeted mouse mutants published every year has been seen as
reviewed in (Brandon et al., 1995; Brandon et al., 1995). It has become feasible to produce
mice with designed genetic alterations ranging from simple gene disruptions and point mutations
to large genomic deletions encompassing several centimorgans, or even to generate specifically
engineered chromosomal translocations. Such mice have since become an valuable new tool
to dissect the functions of individual components of complex biological systems, namely to
produce mouse models of human inherited diseases. Homologous recombination in embryonic
stem cells (ES cells) is a routine technique being used to modify the mouse genome at any
chosen locus (Doetschman et al., 1987; Thomas and Capecchi, 1987). The introduction of the
foreign DNA is either performed by micro-injection into the pronucleus or by retroviral
transduction of embryonic cells (Kilby et al., 1993). This type of manipulation may not only
be used to inactivate (knock-out) a gene but also to generate ”knock-in” mice in which, the
coding region of a different gene or a regulatory element is introduced into the locus. In
contrast to knock-out mice were a ”loss of function” is the aim, a ”gain of function” is
developed in knock-in mice. Furthermore, genes may be replaced by their homologues from
different species, to produce, for example, humanized antibodies or to exchange murine
genes for disease-associated alleles from humans (Moore and Melton, 1995; Zou et al.,
1994). The p53-gene, relevant in pancreatic cancer has been knocked out in mice already and
lead to suppression of p53-dependent apoptosis in these animals (Nikiforov et al., 1996).
1.5.2 In vitro models
The most common in vitro models are based on cell lines. Human pancreatic cell lines are of
particular interest and a wide spectrum is available (e.g. Capan 1 and 2, Panc 1, Colo 357,
MiaPaCa-2, Aspc-1, BxPC-3) [Kalthoff, 1993 #101]. These cell lines have been used to study
many aspects of pancreatic cancer, such as cellular de-differentiation, the promoting or inhibiting
effect of gastrointestinal hormones and other growth factors. Hall and Lemoine showed the
human acinar phenotype was not stable and could transdifferentiate into a ductal phenotype
in vitro (Hall and Lemoine, 1992). Although many studies have been performed and are still
performed using cell lines, the two-dimensional growth of cells alters their behavior in many
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performed using cell lines, the two-dimensional growth of cells alters their behavior in many
ways (Pawlik et al., 2000; Mansbridge et al., 1994; Roberts and Soames, 1993).
Three-dimensional cell culture systems have been established decades ago (Moscona, 1952;
Holtfreter, 1947) trying to overcome some disadvantages of two-dimensional cell culture
systems. It has been shown that multicellular aggregates called ”spheroids” generated from
tumor cells resemble the in vivo situation of a solid tumor better than conventional monolayer
cultures of cancer cells. Carlsson and co-workers showed the outer cell layers of spheroids
exhibited a higher proliferation rate than cells inside the spheroid due to the accumulation of
toxic products or the lack of oxygen (Carlsson and Acker, 1988). Spheroids have been used
as models for the analysis of tumor cell invasion (Bräuer and Hülser, 1990; Bräuer and
Hülser, 1990),  tumor-host interaction (Wilson and Lord, 1987),  and cell-cell contacts (Bridges
et al., 1991; Knuechel et al., 1990). A special characteristic of spheroids is the induction of
morphological and functional cell-differentiation. This was already recognized by Mc Allister
and Co-workers (1967) when they observed a striking  cytological similarity between primary
hamster tumors, corresponding soft-agar colonies and tumors induced by cultivated tumor
cells. These observations were later supported by findings in other tumor systems (Knuechel
et al., 1990). In contrast to spheroids obtained from tumor cells, spheroids obtained from
normal cells e.g. freshly isolated tissue from chicken or mouse embryos, differentiated as
observed in the in vivo tissue and showed typical morphological structures (Mattieu et al.,
1981). Normal cells isolated from adult, differentiated  tissue was shown to remain in an
active and functional state for several weeks if cultivated as spheroids  (Boxberger et al.,
1997; Boxberger et al., 1993).
For the exocrine pancreas only one experimental system was described using explanted
primary duct epithelial cells so far. In this study Oda and co-workers were able to grow
primary pancreatic duct cells in monolayer cultures if these cells were supplied with an
underlying feederlayer which consisted of collagen type I and fibroblasts (Oda et al., 1998).
Although this experiment showed the cultivation of primary duct cells of the exocrine pancreas
is possible, cell culture systems are required that can be held in culture for at least some
weeks. Further these cells should maintain their properties even after being frozen and thawn
and must assure reproducibility if experiments are repeated. Due to the low numbers of
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and must assure reproducibility if experiments are repeated. Due to the low numbers of
passages in culture investigated so far and the different origin of donor tissue (different
patients with different pre-lesions or treatments) it will be difficult to establish such a model
system with primary pancreatic duct epithelial cells.
1.6 Aim of this study
This work is based on the following observation: Earlier observations with a subclone of the
cell line A818, called A818-1, developed three-dimensional “ball-like” structures consisting
of a single layer of pancreatic duct epithelial cells surrounding an inner lumen upon the
prevention of adherence to substratum. Later on, this subclone lost the ability to form these
structures. Consequently, other subclones of A818 were screened for their ability to form
lumenal structures and the subclone A818-6 was found.
The following hypothesis was formulated:
Although being carcinoma cells, all A818-6 cells which are part of this three-dimensional
structure exhibit features of ”normal” pancreatic duct epithelial cells while their
corresponding monolayer cells do not. Therefore A818-6 monolayer cells were propagated
as the ”malignant” phenotype and A818-6 hollow sphere cells as ”benign” phenotype of one
cell line.
Following this hypothesis the purpose of this work was to show how ”normal” A818-6
hollow sphere cells are in comparison to their corresponding monolayer cells and to find out
whether this model is suitable to study important questions associated with development of
pancreatic cancer.
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The work was subdivided into three parts:
1) Establishment of the A818-6 cell culture system including the following steps:
a) Determination of the best seeding density of cells.
b) Determination of the best coating material for cell culture plates.
c) Determination of the best cell culture medium and supplements.
d) Establishment of a cell-collecting method using a micromanipulator to divide
three-dimensional structures from undesired cells.
2) Characterization of the A818-6 cell culture system:
a) Morphologically
- Cell adhesion
- Polarity
- Differentiation marker antigens
b) Physiologically
- Proliferation
- Secretion
- Differentiation marker antigens
3) Analyses on morphoregulatory factors using the A818-6 system as a model:
a) Growth factors and cytokines
- stimulatory
- inhibitory
b) Mesenchymal influence
- Co-cultures
- Conditioned medium
c) Epimorphin
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2 Materials and Methods
2.1 Materials
2.1.1 Cell culture media, components and material
Basal Medium Producer/Company
Supplements
RPMI 1640 Life Technologies, Karlsruhe, Germany
FCS 10 % 
Glutamine 2mM
Sodium pyruvate 1mM
Penicillin 100 units/ml
Streptomycin 100 µg/ml
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Hyclone Labs, Logan, UT, USA
Basal Medium Producer/Company
Supplements
Fibroblast Growth Medium PromoCell, Heidelberg/Germany
FCS 10 %
Insulin 5µg/ml
bFGF 1ng/ml
Gentamicin 50ng/ml
Amphotericin B 50ng/ml
Hyclone Labs, Logan, UT, USA
Basal Medium Producer/Company
Supplements
DMEM Life Technologies, Karlsruhe, Germany
FCS 10 % 
Glutamine 2mM
Sodium pyruvate 1mM
1x NEAA
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Hyclone Labs, Logan, UT, USA
PromoCell, Heidelberg/Germany
PromoCell, Heidelberg/Germany
PromoCell, Heidelberg/Germany
PromoCell, Heidelberg/Germany
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All standard laboratory plastic ware, tissue culture flask and dishes of tissue culture grade
were obtained from Nunc (Roskilde, Denmark). Culture dishes of microbacteriological grade
and plastic pipettes were bought from Greiner (Solingen, Germany).
Producer/CompanyIncubators
B6
3164 Water Jacketed
Heraeus, Hanau, Germany
Forma Science, Marietta, Ohio, USA
Producer/CompanyCentrifuges
Centrifuge 5402
Biofuge pico
Rotina 48R
Eppendorf-Netheler-Hinz, Hamburg, Germany
Heraeus, Hanau, Germany
Hettich, Tuttlingen, Germany
Producer/CompanyPhotometers
BioPhotometer
HT-2
Eppendorf-Netheler-Hinz, Hamburg, Germany
Anthos Labtech, Salzburg, Austria
Producer/CompanyMicroscopes
Axiovert +
Mircomanipulator 5179
Axioskop 2
BH-2
LSM 510
EM 10
Zeiss, Jena, Germany
Eppendorf-Netheler-Hinz, Hamburg, Germany
Zeiss, Jena, Germany
Olympus, Wuppertal, Germany
Zeiss, Jena, Germany
Zeiss, Oberkochen, Germany
Producer/CompanyReagents
PBS
HBSS
Trypsin/EDTA
Trypan Blue solution (0.5%)
Collagen R
Matrigel
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Serva, Heidelberg, Germany
Serva, Heidelberg, Germany
Material and Methods                                                                                         32
2.1.2 Bacteriological reagents
2.1.3 Bacteria
2.1.4 Plasmids
pKAT 1.gag/pol.ATG
penv
pCMV-VSV-G
pBluescript SK (+/-)
pcDNA3.1
Tjmother
pEGFP/neo
Stratagene, La Jolla, CA, USA
Invitrogen, Leek, Netherlands
Viagene, San Diego, CA, USA
Clontech,Palo Alto, CA, USA
Dr.Dull at Cell Genesis Corp
Dr.Dull at Cell Genesis Corp. 
Dr.Robins, Pittsburgh, USA
 
Producer/CompanyPlasmid
Producer/CompanyBacteria
E.coli TOP10F´
K12-derived strain
Genotype
F´{lacIq, Tn10(TetR)} mcrA
∆
∆
(mrr-hsdRMS-mcrBC) φ 80lacZ
M15∆ lacX74 deoR recA1 araD139
∆ (ara-leu)7697 gal/U gal/K rpsL
(StrR) endA1 nupG
Invitrogen, Leek, Netherlands
CompositionLB-Medium
Ampicillin (50µg/ml)
Bacto-tryptone (10.0 g)
Yeast Extract (5.0 g)
NaCl (5.0 g)
Bacto-Agar (15.0 g)
For liquid medium mix tryptone, yeast extract, NaCl and 
adjust to 1l with distilled water.
For solid LB-plates add agar.
Autoclave 20 min. at 120°C
Let cool to 50°C and add Ampicillin (50µg/ml)
Agarose
Ampicillin
Bacto-Agar
Bacto-tryptone
Yeast Extract
Life Technologies, Karlsruhe, Germany
Sigma Chemical Co, St. Louise, MO, USA
Difco Labs, Detroit, MI, USA
Difco Labs, Detroit, MI, USA
Difco Labs, Detroit, MI, USA
Producer/CompanyReagents
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2.1.5 Molecular biological reagents
2.1.6 Staining reagents
Producer/CompanyEnzymes
DNATaq-Polymerase
SuperscriptII Reverse Transcriptase
RNase Inhibitor
T4-Ligase
Life Technologies, Karlsruhe, Germany
Life Technologies, Karlsruhe, Germany
Perkin Elmer, Hamburg, Germany
Boehringer, Mannheim, Germany
Producer/CompanyRestriction enzymes
ClaI
EcoRI
BamHI
Sal I
Boehringer, Mannheim, Germany
Boehringer, Mannheim, Germany
Boehringer, Mannheim, Germany
Boehringer, Mannheim, Germany
Producer/CompanyKit-systems
BCA-Assay
Endofree Plasmid Kit
PolyTract 1000 mRNA
RNA-Clean
ECLWestern blot detection
Gel-Extraction-Kit
Pierce, Rockfors, IL, USA
Quiagen, Hilden, Netherlands
Promega, Madison, WI, USA
AGS, Heidelberg, Germany
Amersham-Buchler, Braunschweig, Germany
Quiagen, Hilden, Netherlands
Producer/CompanyReagents
Mayers Hemalaun Sol.
DAPI
Annexin V/Propidium iodine
Trypan Blue solution (0.5%)
Vectastain/Elite
Vectashild
DAB
Ethidium Bromide
Coomassi-Blue
Merck, Darmstadt, Germany
Boehringer, Mannheim, Germany
Molecular Bioprobes, Eugene, OR, USA
Life Technologies, Karlsruhe, Germany
Vector Labs, Burlingame, CA, USA
Vector Labs, Burlingame, CA, USA
Vector Labs, Burlingame, CA, USA
Merck, Darmstadt, Germany
Merck, Darmstadt, Germany
Producer/Company
Oligo-dT
dNTP´s
Miscellaneous
Perkin Elmer, Hamburg, Germany
Pharmacia, Uppsala, Sweden
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2.1.7 Antibodies and recombinant proteins
Producer/CompanyPrimary antibodies against
cell-adhesion associated molecules
E-Cadherin
cateninα−
γ−catenin
β−catenin
Integrin 1−β
Integrin 6−β
Integrin V−α
Desmoglein
Symplekin
p120
L1
Primary antibodies against
cell-cycle associated molecules
Cyclin B
Cyclin D1
Cyclin D3
cdc2
cdk2
cdk4
p21/Cip
p27/Kip
p16/INK
Ki67
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Alexis, Grünberg, Germany
Alexis, Grünberg, Germany
Transduction Laboratories, Lexington, KY, USA
Progen, Heidelberg, Germany
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
β− actin Sigma, Saint Louise, MI, USA
Paxillin
FAK
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Transduction Laboratories, Lexington, KY, USA
Primary antibodies against
differentiation marker antigens
carbonic anhydrase II (CAII)
mucin-1
CEA
BGP
NCA 95
Dr. Nishimori, Kochi, Japan
Prof. Olija Finn, Pittsburgh, USA
Ch. Wagener, UKE, Hamburg, Germany
M. Neumeier, UKE, Hamburg, Germany
Ch. Wagener, UKE, Hamburg, Germany
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Producer/CompanyPrimary antibodies against
miscellaneous antigens
HGF/SF
c-met
IL-13
c-Raf
p53
VEGF
GSK3−β
−βTGF (pan-specific)
G 7−γ
R&D Systems, Wiesbaden, Germany
R&D Systems, Wiesbaden, Germany
Pharmingen, San Diego, CA, USA
Transduction Laboratories, Lexington, KY, USA
Sigma, Saint Louise, MI, USA
R&D Systems, Wiesbaden, Germany
Transduction Laboratories, Lexington, KY, USA
R&D Systems, Wiesbaden, Germany
Santa Cruz Inc., Santa Cruz, CA, USA
Epimorphin Y. Hirai, Sumitomo Industries, Yokohama, Japan
Rekombinant Proteins (cytokines,
growth factors)
−αTGF
HGF/SF
TNF−α
Epimorphin
Activin A
Inhibin
Fas-Ligand
TRAIL
EGF
bFGF
−βTGF
R&D Systems, Wiesbaden, Germany
R&D Systems, Wiesbaden, Germany
R&D Systems, Wiesbaden, Germany
Knoll/BASF, Ludwigshafen, Germany
Y. Hirai, Sumitomo Industries, Yokohama, Japan
R&D Systems, Wiesbaden, Germany
R&D Systems, Wiesbaden, Germany
R&D Systems, Wiesbaden, Germany
R&D Systems, Wiesbaden, Germany
R&D Systems, Wiesbaden, Germany
PromoCell, Heidelberg/Germany
Knoll/BASF, Ludwigshafen, GermanyIFN −γ
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2.1.8 Cell lines
The following cell lines were used in this study  and either bought from the American Type
Culture Collection (ATCC) or established in our laboratory (see origin). The characterization
in columns 2-3 was taken from the original publication or is based on personal communication
with Prof. Dr. Klöppel (Institute of Pathology, CAU, Kiel, Germany).
Abbreviations: Pa.: Pancreas; Ca.: Carcinoma; PT.: primary tumor; AS.:Acites;
LM.: Liver metastasis; n.d.: not determined
Producer/ATCCCell line
A818-2
A818-4
A818-5
A818-6
A818-7
Capan-1
Capan-2
Panc-1
BxPC3
AsPC-1
Kif-5
PTF-994
293T
L-428
Primary 
tumor
Tumor-grading
Pa. Adeno-Ca.,
AS
Pa. Adeno-Ca.,
AS
Pa. Adeno-Ca.,
AS
Pa. Adeno-Ca.,
AS
Pa. Adeno-Ca.,
AS
Pa. Adeno-Ca.,
LM
Pa. Adeno-Ca.,
PT
Pa. Adeno-Ca.,
PT
Pa. Adeno-Ca.,
PT
Pa. Adeno-Ca.,
AS
skin-fibroblasts
Pa.-fibroblasts
highly  differentiated; 
Grade I
highly  differentiated; 
Grade I
highly  differentiated; 
Grade I
highly  differentiated; 
Grade I
well  differentiated; 
Grade II
low  differentiated; 
Grade II-III
medium  differentiated; 
Grade II
medium  differentiated; 
Grade II
fetal-kidney-cell
s
n.d.
n.d.
PhD-work Heringlake
et al. 1991
Kalthoff et al., 1993
Oncogene. 8:289-298
PhD-work Heringlake
et al. 1991
Lehnert et al., 2000 
Ph.D.-thesis
PhD-work Heringlake
et al. 1991
ATCC, CRL-1687
ATCC, CRL-1469
ATCC, CRL 1575
ATCC, CRL-1682
ATCC, HTB 79
ATCC, HTB 80
own laboratory
own laboratory
DSMZ, Braunschweig, 
Germany DSM ACC 197Hodgkin´s 
disease
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2.1.9 Animals
2.1.10 Chemicals
All fine chemicals were obtained from the following Companies and their grade of purity was
at least per analysis.
Merck, Darmstandt, Germany
Sigma-Aldrich, Saint Louise, MI, USA
Serva, Heidelberg, Germany
2.2 Methods
2.2.1 Standard cell culture
Cell lines were cultured in RPMI 1640 supplemented with 10 % FCS, 2mM glutamine, 1mM
sodium pyruvate, 100 units penicillin/ml, 100 µg streptomycin/ml. 293T- cells were cultured
in DMEM supplemented with 10 % FCS, 2mM glutamine, 1mM sodium pyruvate, 1x non
essential amino acids (NEAA). Fibroblasts were grown in Fibroblast Growth Medium containing
all supplements and 10% FCS. Prior to immunoprecipitation experiments tumor cells and
fibroblasts were cultured under serum-free conditions for 24 h. All cell lines were routinely
checked for mycoplasma contamination by the PCR-based mycoplasma detection kit from
TaKaRa (by Bio Whittaker Europe, Taufkirchen/Germany).
Fresh medium was added every second or fourth day, depending on the cell line. Old medium
was discarded, cells were washed with PBS (pre-warmed to 37°C) once to remove all cell
debris and new medium (pre-warmed to 37°C) was added (15 ml/T75-flask). Cells were split
after they reached a confluency of approximately 80%. The old medium was discarded, cells
were washed with PBS and Trypsin/EDTA-solution (0.25% Trypsin/ 0.01% EDTA) was
added. Cells were incubated at 37°C for 5-30 min., depending  on the cell line. Trypsin-activity
was stopped by adding an equal amount of medium and afterwards cells were centrifuged at
1,000 rpm for 5 min. The supernatant was discarded, cells were resuspended in fresh medium
Producer/Company
SCID-bg
Mice
Charles-River; Sulzfeld, Germany
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1,000 rpm for 5 min. The supernatant was discarded, cells were resuspended in fresh medium
and seeded into a new cell culture flasks. The average splitting-ratio was 1:3. Prior to some
experiments cells were counted in a Neumeier-Chamber using Trypan Blue solution (0.5% in
PBS) to discriminate living from dead cells.
For long-term monolayer culture, cells were grown in T75 cell culture flasks. For long-term
storage cells were frozen in liquid nitrogen. The storage solution consisted of FCS/10%
DMSO.
2.2.2 Three-dimensional cell culture
2.2.2.1  Suspension on solid agarose
For three-dimensional growth 1-5x105 cells were seeded into pre-coated 6-well plates. The
coating solution contained agarose at 31mg/ml mixed with RPMI 1640 (without supplements,
pre-warmed to 37°C) at a ratio of 1:3. 1ml was added to each well. The agarose-solution was
autoclaved prior to use. This coating prevented cell adhesion to the tissue culture dishes.
Cells were seeded in a total volume of 5 ml cell culture medium per well. As it was impossible
to remove all medium without loosing the cells in suspension, new cell culture medium was
added by removing 2-3 ml of the old medium carefully and replacing it with fresh one.
2.2.2.2 Collagen type I gels
10 ml NaOH (0.34 M) were added to 20 ml of ten-fold concentrated RPMI 1640 medium and
used as stock solution. In 0.4 ml of this solution 5x104-1x105 cells were resuspended, mixed
with 1.7ml of collagen-solution and poured into one well of a 6-well plate. The gel became
solid after 15 min. and was overlaid with 2 ml of cell culture medium.
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2.2.2.3 Matrigel
Matrigel is a complex mixture components of mammalian extracellular matrix derived from
Engelbreth-Holm-Swarm tumor cells. All pipettes and culture dishes were cooled to -20°C
prior to use. The cell culture medium was placed on ice one hour before use.  Matrigel was
carefully thawn on ice. 5x104-1x105cells or A818-6 hollow spheres were quickly resuspended
in 2ml of cold medium and mixed with 2 ml of Matrigel. 2 ml of this solution was poured
into one well of a 6-well plate and incubated at 37°C for 30 minutes. After Matrigel became
solid, 2-3 ml of cell culture medium were added.
2.2.3 Co-cultivation of tumor cells with fibroblasts
Fibroblast co-cultures were carried out with dermal-derived-fibroblasts (KIF-5) and pancreas-
derived fibroblasts (PTF994). These fibroblasts were co-cultured with the tumor cell lines
A818-6, Capan-1, Capan-2, BxPC3 and Panc-1. In a first experimental set-up, fibroblasts
were mixed at a ratio of 1:1 with tumor cells after trypsinization. The mixture was seeded
into agarose-coated culture-dishes. As a control, tumor cells were seeded without fibroblasts.
In a second experimental set-up, fibroblasts were seeded under standard cell culture conditions
and grown in monolayer culture. After reaching confluency, freshly trypsinated tumor cells
were seeded on top of these fibroblast monolayer cultures and were incubated for 48 h. In a
third set-up, A818-6 pre-mature hollow spheres (5-6 days old) were seeded on top of fibroblast
monolayer cultures. Two days before co-culturing fibroblasts with tumor cells, fibroblast
were adapted to RPMI 1640 medium by mixing both media at a ratio of 1:1. At the day of the
experiment both, fibroblasts and A818-6 cells were incubated in RPMI 1640 medium. Fibroblast-
free protein from fibroblast-stimulated A818-6 hollow spheres was obtained by transferring
hollow spheres to non-coated tissue culture plates. Fibroblasts adhered to this plates but
hollow spheres did not.
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2.2.4 Immunostaining
2.2.4.1 Immunohisto-/cytochemistry
For immunohisto-/cytochemistry either human or murine pancreatic tissue or cell lines were
used. After surgical treatment of patients or mice, one fraction of the resected pancreatic
tissue was immediately frozen in liquid nitrogen. Another fraction was inspected by pathologists
to determine tumor-type and grade. Prior analysis 5 mm blocks of tissue were cut of the
primary tissue block and cut in 5µm-thin slices using a cryotom. Three to five of this slices
were mounted on a microscopic slide, air-dried for at least 3 h and fixed in actetone for 5
min. Cells from cell lines were harvested by trypsinization or scraping and cytocentrifugation
onto microscopic slides. Completely developed hollow spheres were centrifuged onto protein
pre-coated microscopic slides from Marienfeld (Darmstadt, Germany). Cells on microscopic
slides were fixed by incubation with acetone for 5 min. Fixed tissue and cells were stored at
-20°C in plastic bags under vacuum conditions.
Prior analysis, the frozen samples were allowed to reach room temperature and  were re-hydrated
in PBS. Staining was then carried out by incubating for 1 h with a primary antibody followed
by three washes with PBS. Primary antibodies were used in concentrations ranging from 5-20
µg/ml. The incubation time for the secondary, horseradish peroxidase-conjugated antibody
was 30 min. The secondary antibodies were used at concentrations recommended by the
supplier and were diluted in PBS containing 1% human serum. Primary antibodies were
diluted in PBS/1% bovine serum albumin (BSA). Detection was carried out with diamino-
benzidine (DAB) as a substrate for  the  horseradish peroxidase resulting in a brown precipitate
in case of a reaction. All samples were counter-stained with hemalaun which stains nuclei of
cells blue.
Evaluation of results with the antibodies KiS5 and KiS2 was carried out microscopically by
counting positive (brown) cells and negative cells (blue). 200 to 300 cells were counted in
total, repeated three times. The medians and standard deviations were calculated and results
expressed as ”% of positive/negative cells”.
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2.2.4.2 Immunofluorescence
The indirect immunofluorescence staining was performed in 5 ml plastic tubes from Nunc
(Denmark). Monolayer cells were scraped off the plates, transferred to tubes and centrifuged.
Hollow spheres were directly transferred into the tubes. The supernatants were discarded and
a single PBS wash was performed. 2 ml of ice cold methanol (70%) was added to pre-fix and
permeabilize cells followed by incubation on ice for 3 minutes . All cells were then washed
with ice cold PBS containing 0.05% sodium azide three times and stained with the primary
antibody for 1h. All primary antibodies were used in concentrations ranging from 5-20
µg/ml. After washing three times with ice cold PBS, incubation with the secondary antibody
(Cy3-conjugated goat-anti-mouse IgG+IgM) was carried out for 30 min. A final fixation step
was carried out by adding 4% Paraformaldehyde to the stained cells after washing. Primary
antibodies were diluted in PBS/1% BSA. The secondary antibodies were used at concentrations
recommended by the supplier and were diluted in PBS containing 1% human serum.
Visualization was carried out with an Axioskop2-fluorescence-microscope for epifluorescence
or with a laser-scanning microscope LSM 510 for confocal microscopy both from Carl Zeiss
Jena, Germany.
2.2.5 Electron microscopy
Electron microscopy was performed by Prof. Markus M. Lerch at the University of Münster,
Germany as part of a cooperation within the DFG-grand this work was founded by.
For transmission electron microscopy confluent cells were harvested by scraping and cells or
hollow spheres in suspension were concentrated by 100 g centrifugation, fixed in ice cold 2%
glutaraldehyde/2% formaldehyde solution at pH 7.4 with 0.1M cacodylate buffer. Fixed cells
and spheres were post-fixed in 1% osmiumtetroxide and embedded in Epon. Silver thin
sections were contrasted with uranyl and lead and viewed on a Zeiss EM 10 electron microscope.
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2.2.6 Cytokine and growth factor treatment of A818-6 cells
Cytokines, growth factors and apoptosis-inducing factors were either added to freshly seeded
A818-6 cells or completely developed hollow spheres (for concentrations compare Tab.1 in
Results). In a second experimental setting a HGF-neutralizing antibody or a epimorphin-
neutralizing antibody (MC-1) were used in a concentration of 50 µg/ml to  neutralize exogenously
added HGF/epimorphin or to block intrinsic HGF/epimorphin produced by the cells. All
cytokines and corresponding antibodies were added on day 2, 5 and 7 after seeding and were
replaced together with fresh cell culture medium. These experiments were performed in
6-well plates and the cultures were checked by microscope daily.
2.2.7 Transfection of established cell lines and generation of transient VSV-G 
pseudotyped retroviral supernatants
The established ”producer cell line” for the production of retroviral supernatants 293T was
used to generate retroviruses carrying the gene encoding for the ”enhanced green fluorescent
protein” (EGFP). These retroviruses were used to tranduce fibroblasts and A818-6 cells
enabling them to express the EGFP-gene and to become fluorescent under UV-light.
24 h prior to transfection, 1 x 106 293T cells were seeded into Primaria plates (Falcon #
3803). 10 mg of each retroviral plasmid vector (pEGFP/neo), 7 mg of the packaging plasmid
pKAT 1.gag/pol.ATG and 7 mg of pCMV-VSV-G were then co-transfected into 293T cells
using calcium phosphate co-precipitation (Wigler et al., 1979). The next day, fresh medium
was added and viral supernatants were harvested 24 and 48 h later, filtered through 0.45 mm
low protein binding AcrodiscTM filters (#4184, Gelman Sciences, Ann Arbor, MI) and stored
at -80°C.
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2.2.8 Transduction of A818-6 cells and fibroblasts
1 x 105 A818-6 cells and Kif-5 fibroblasts were seeded into 6 cm2 dishes containing complete
medium and 8 mg/ml polybrene. 24 h later, pEGFP/neo retroviral supernatants generated
from 293T producer cell line were used to infect these cell lines at a multiplicity of infection
(MOI) of 10. For long term evaluation of gene expression and pro-vector copy analysis,
pEGFP/neo-transduced A818-6 cells were selected in G418 for two weeks using 1,000 µg/ml.
For fibroblasts 500 hollow spheresµg/ml G418 were used for selection. After successful
transduction the retroviral mRNA is converted into DNA by the virus reverse transcriptase
and integrated into the host-genome leading to a permanent expression of the EGFP-protein
under a CMV-promotor which is part of the retroviral construct.
2.2.9 Proliferation assays with A818-6 cells
2.2.9.1 KiS5/KiS2-staining
KiS5 and KiS2 are antibodies which were developed by the group of Prof. Parwaresch at the
Institute of Pathology, CAU, in Kiel. KiS5 detects the proliferation associated antigen Ki67
being expressed in all phases of the cell cycle except the G0-phase. KiS2 binds to a 100-kd
nuclear protein expressed in S, G2, and M phases of the cell cycle but not G1/G0 (Heidebrecht,
1997 and Rudolph, 1998 ).
2.2.9.2 Telomerase assay (telomeric repeat amplification protocol; TRAP-assay)
The telomerase assay was performed under guidance of Dr. Klaus Heidorn from the Institute
of Pathology, CAU in Kiel as previously described (Klapper et al., 1998; Krupp et al., 1997).
Protein was extracted from A818-6 hollow spheres or from A818-6 monolayer cells using
standard CHAPS buffer  (Krupp et al., 1997). A 5’-fluorescein labeled reverse primer ”CX-ext”
was used to obtain fluorescence-labeled PCR products. The inclusion of an internal amplification
standard  (ITAS) permitted quantitative comparisons, and ITAS was prepared by PCR essentially
as described (Wright et al., 1995). As template the gene of the RNA component of Thermus
aquaticus RNAse P was used (Hartmann and Erdmann, 1991; Klapper et al., 1998). The
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values shown in Results were obtained  by comparison with a calibration curve for extracts
(0.04-0.2 µg) from the Hodgkin´s disease human tumor cell line L-428. Aliquots of the
TRAP-assay (2 µl) were analyzed by capillary electrophoresis (ABI prism 310). One example
of results is shown below (Fig. 6). Integrated values were added up for all telomerase
products (black peaks) representing five telomeric hexamer repeats and calibrated by dividing
by the value for ITAS. Values and standard deviations calculated from all data are summarized
in a graph in Results (Fig.11). The raw data of this experiment are listed in the addendum to
Results.
Fig.6
 Fig. 6: Example for one measurement of telomerase activity in A818-6 monolayer cells.
ITASprimer-dimer
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2.2.9.3 Analyses of cell cycle associated proteins
Cell cycle associated proteins were analyzed by Western blot as explained under point 2.2.11.
The amounts of different cell cycle associated proteins were compared between A818-6
monolayer cells and A818-6 hollow sphere cells using monoclonal antibodies to detect these
proteins in protein-lysates.
2.2.10 SDS/Polyacrylamide Gel Electrophoresis
Sodium-dodecyl-sulfate-polyacrylamide-gel-electrophoresis (SDS-PAGE) is a method used
to fractionate molecules according to their size. SDS-PAGE was used to separate the different
proteins in protein-lysates obtained after the lysis of cells from each other following the
following protocol: (Laemmli)-gel preparation. Volumes given are sufficient for small (8 cm
x 10 cm x 0.75 mm) gel format (10 ml). Volumes were scaled up as needed.
1. Pouring the Separating Gel
A gel-system from Biometra was used. First a separating gel was prepared by mixing the
components given below. TEMED was added just prior pouring the gel. This separating gel
was overlaid with n-butanol and allowed to polymerize. A stacking gel of 4% was poured on
top of the separating gel. A comb with 10 slots was inserted before the gel polymerized.
15% Separating-gel Composition
destilled water
1.5 M Tris-HCl, pH 8.8	
20% (w/v) SDS
Acrylamide/Bis-acrylamide
(30%/0.8% w/v)
10% (w/v) ammonium persulfate
TEMED
Total Volume
		2.4 						ml
		2.5							ml
		0.05					ml
		5.0 						ml
		0.05					ml
		0.005		 ml
10.005 		ml
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Sample-preparation and electrophoresis:
The Biometra electrophoresis chamber was assembled according to the manufacturers
instruction and filled with 1x running buffer.  The comb with 10 slots allowed to load up to
40µl of probe per slot. Protein-lysates were mixed with the concentrated sample-buffer at  a
ratio of 4:1, boiled at 95°C for 5 min. and then directly loaded on the gel. The run was started
with applying 60W until all samples were collected at the border between stacking- and
separation-gel. Separation was carried out at 120W for approximately 2 h. The blue color
bromophenol blue was used as a marker for the migration-distance of probes. After the run
the glass plates were carefully removed and the gel was prepared for blotting or staining e.g.
with Coomassi-blue.
4% Stacking-gel Composition
destilled water
0.5 M Tris-HCl, pH 6.8
20% (w/v) SDS
Acrylamide/Bis-acrylamide
(30%/0.8% w/v)
10% (w/v) ammonium persulfate
TEMED
Total Volume
                                  
3.075 ml
1.25 		ml
0.025 ml
0.67 		ml
0.025	ml
0.005 ml
5.05 		ml
Sample-buffer (Laemmli) 4x Composition
distilled water
0.5 M Tris-HCl
Glycerol
10% (w/v) SDS
beta-mercaptoetanol
0.05%(w/v)
bromophenolblue
                                  
4.0	ml
1.0 ml
0.8 ml
1.6 ml
0.4	ml
0.2 ml
5x Running buffer, pH 8.3 (1 liter) Composition
15g
72g
		5g
destilled water to 1 liter
Tris Base
Glycine
SDS
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with Coomassi-blue.
Coomassi-blue staining of PAGE-gels
Gels were transferred into Coomassi-blue solution (approximately 200 ml), shaked gently
and incubated for up to one hour at RT. Destaining was performed by transferring the gel into
destaining buffer. After replacing the buffer up to three times protein bands are visible
without background.
2.2.11 Western blot analysis
Buffers:
Blotting-buffer (10x) Composition
Tris-Base
Glycin
Methanol
121.14 g
142.6 		g
20% (v/v)
Dissolve Tris and Glycin in 800 ml of destilled 
water and fill up to 1 liter. Add methanol when 
preparing 1x buffer by mixing 1part of 10x 
buffer, 7 parts destilled water and 2 parts of 
methanol.
PBST Composition
PBS
Tween 20
Thimerosal
400 ml
100 ml
0.01% (w/v)
Destaining-solution Composition
Ethanol
Acetic acid
400	ml
100	ml
Fill up to 1,000ml with water and store at RT
Coomassie Blue R-250
Ethanol
Water
Acetic acid
0.25g
100	ml
100	ml
		25	ml
Dissolve the dye completely and then add 
acetic acid. Fill up to 250 ml with water.
Staining-solution Composition
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Protein Extraction from adherent cells and A818-6 hollow spheres
Cells were washed with PBS once and 500 µl RIPA-buffer was added per well of a 6-well
plate. 3 ml were used for a T25-flask. All steps were carried out on ice. After lysis, cell debris
was removed by centrifugation at 14,000 rpm for 15 min. The supernatant was either aliquoted
and stored at -80°C or a BCA-assay was performed to measure the total amount of protein in
a probe. The BCA-assay was obtained from Pierce, Rockfors, IL, USA and performed as
recommended by the manufacturer. The results were obtained as colorimetric values measured
by a photometer (anthos II). The concentrations were determined using a titration of bovine
serum albumin from 1,000 µg/ml to 15.625 µg/ml total protein. A818-6 hollow spheres were
centrifuged, the pellet was washed with PBS. After further centrifugation the supernatant was
discarded and cells were lysed in RIPA-buffer added to the centrifugation tube.
SDS-PAGE
After the protein concentration was determined SDS-PAGE was performed as described
above to separate the proteins by size. In general, 20 µg total protein was loaded per slot. A
protein-size marker (RainbowTM, Amersham, Braunschweig) was used to check the correct
sizes of the expected protein bands after Western blot analysis.
Blocking-buffer Composition
PBST
slim milk powder
100	ml
5g
Dissolve milk powder in 100 ml 
RIPA-buffer Composition
PBS
NP40
Sodium-deoxycholate
SDS
Protease Inhibitor
(Complete Stock Boehringer)
1.0%
0.5%
0.1%
1 tablet added to 50 ml
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sizes of the expected protein bands after Western blot analysis.
Western blot assembly and performance
Filter paper was obtained from Whatman and the PDVF-membrane (polyvinillidene difluoride
membrane) was bought from Immobilon P, Millipore Corp. Bedford, USA.
Prior to blotting the PDVF-membrane was washed in methanol for 5 minutes followed by
destilled water for another 5 min. and blotting buffer. Filter paper was pre-wet in blotting
buffer. The blot was assembled as shown above and the transfer was performed at 400 mA
for 1.5 h. After proteins were transferred to the PDVF-membrane the membrane was incubated
in blocking buffer at 4°C over night to block all unspecific binding-sides. The transfer
efficiency and later the correct protein size was checked by using a RainbowTM protein
marker.
Detection
After blocking the membranes with blocking buffer they were washed in PBST and then
incubated with the primary antibody. Primary antibodies were diluted in 10 ml PBST/1%
slim milk in concentrations of 5-10 µg/ml. Incubation with the primary antibody was carried
out at RT for an hour and gentle agitation. Subsequently the membranes were excessively
washed with PBST and the secondary antibody was added. Secondary antibodies were diluted
in 10 ml PBST/1% slim milk as well and were conjugated with the enzyme horseradish-
peroxidase (HRP). Incubation was carried out for 30 min. at RT and gentle agitation followed
by excessive washes with PBST. The membranes were placed in plastic covers and ECL-solution
was added as recommended by the manufacturer. ECL is a substrate for HRP and its metabolism
results in light-emission which can be detected with a x-ray film (Kodak Biomax). All blots
+
-
filter paper
PDVF-membrane
gel
sponge
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results in light-emission which can be detected with a x-ray film (Kodak Biomax). All blots
were normalized with an antibody against β-actin (42kDa) to prove the loading of equal
amounts of protein per lane.
2.2.12 Immunoprecipitation
Immunoprecipitation was performed with supernatants from A818-6 hollow spheres or
monolayer cultures, fibroblasts and co-cultures from hollow spheres and fibroblasts. 1-3 µg
of primary antibodies were added to approximately 2 ml of cell free supernatant and rotated
at 4°C overnight. Protein-G-Sepharose (Amersham Parmacia Biotech AB, Uppsala, Sweden)
was equilibrated for the corresponding cell culture medium over night and then added to the
primary-antibody solution followed by rotation for 30 min. at 4°C. Sepharose-beads were
collected by centrifugation at 14,000 rpm for 2 min. and washed four times with TNE-buffer.
The pellet was then resolved in 1x Laemmli-buffer, boiled for 5 minutes at 95°C and immediately
loaded onto a 15% SDS-PAGE-gel for separation. Detection was carried out as described for
Western blot analyses.
2.2.13 RNA- and mRNA-isolation from cultured cells
RNA-isolation
Total-RNA was isolated from adherent cells and A818-6 hollow spheres using the RNA-CleanTM
system combining the classical  ”Guanidin-thiocyanate method” with a Phenol-chloroform
extraction to a “single-step method”.
Cells grown in 6-well plates were lysed with 1ml of RNA-Clean per well on ice, 6 ml were
used for T75-flasks. The viscous solution (genomic DNA) was transferred into 2 ml Eppendorf-
tubes and 100 µl chloroform was added per ml of lysate. The mixture was vortexed for 15
seconds and incubated on ice for 10 min. followed by centrifugation at 14,000 rpm for 5 min.
TNE-buffer Composition
Tris pH8, 
NaCl, 
NP40, 
EDTA
0.5M 
0.15M 
0.1% 
0.125M 
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seconds and incubated on ice for 10 min. followed by centrifugation at 14,000 rpm for 5 min.
The clear, upper phase was transferred into a new tube taking care of not pipetting material
from the interphase which contains proteins and carbohydrates. An equal volume of iso-propanol
was added and the tubes were placed on ice for 30 min. after a gentle agitation. The following
centrifugation was performed at 14,000 rpm for additional 30 min. After this step a RNA-pellet
is visible at the bottom of the tube. The supernatant was discarded and the pellet was washed
with icecold ethanol (70%) to remove salts. This step was repeated two times followed by
air-drying of the pellet. RNA-pellets were stored dry at -80°C. Prior use, pellets were re-hydrated
in 30-50 µl destilled, RNase-free water or TE-buffer (100mM Tris-HCl, pH7.5, 10mM
Na2EDTA).
mRNA-isolation
The PolyTract 1000TM mRNA Kit from Promega, Madison, WI, USA was used for mRNA-
isolation from total RNA. This system uses magnetic beads conjugated with oligo-dT strands.
These oligo-dT strands anneal with the 3’-polyA-tails of mRNA. The beads  with the “catched”
mRNA are collected with a magnet washed with SCC-buffer and eluted with water. The
isolation was carried out strictly following the manufacturers manual using between 0.1-1mg
of total RNA prior isolated with RNA-CleanTM.
Agarose gel electrophoresis for RNA
CAVE: Use only RNase free glassware and plastics! Work with gloves! Prepare all solutions
using DEPC treated and sterilized miliQ water.
2-3 g agarose were dissolved in 170 ml DEPC treated water, 20 ml 10 x MOPS were added
and the solution was cooled in a waterbath to 50 ºC. Formaldehyde was filtered over Whatman
3MM and 10.2 ml were added to agarose. The gel was poured immediately. 25 µl sample
buffer was added to the RNA samples (1-3µg poly(A) or 10-30µg total in 5 µl DEPC water).
The samples were heated for 15 min. at 65 ºC,1 µl ethidiumbromide was added and loaded on
gel. The run was stopped after bromophenol blue had migrated 10 cm. The gel was photographed
on UV transilluminator without further staining.
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Figure 7
Fig.7. Representative picture of a 1%-RNA-gel with ribosomal RNA bands
2.2.14 Polymerase chain reaction (PCR)
PCR has been used as a standard method for the amplification of DNA since years and many
different protocols are used. Therefore a standard PCR protocol is explained here and details
different from this protocol are described in the corresponding result-section. PCR-reactions
10 x MOPS/EDTA Composition
MOPS
Na-acetate
EDTA
		0.2	M 
50	mM 
10	mM 
 
Sample buffer Composition
10xMOPS
deionised formamide
formaldehyde
DEPC water
glycerol
bromophenol blue (10% solution)
150	µl 
750	µl 
240	µl
100	µl
100	µl 
		80	µl 
Keep in small portions frozen at -20 ºC. 
Slot with rests of contaminating DNA
28S-rRNA
18S-rRNA
5S-rRNA
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different from this protocol are described in the corresponding result-section. PCR-reactions
were performed in 50 µl volumes. All PCR reactions were carried out as ”hot-start” PCRs.
This modification reduces unspecific annealing of primers in the first reaction-cycle.
Subsequently, a 50 µl-reaction was set up in two reaction tubes. The first contained PCR-buffer,
dNTPs, MgCl2 and template-DNA, the second tube contained PCR-primers and Taq-
polymerase. The mix in the first tube was covered with a drop of mineral oil, placed in the
PCR-cycler and heated to 80°C. This temperature was kept for 5 min. and the content of tube
number two was added.
Thermal cycling was carried out as follows: denaturation at 95°C for 1min., annealing at
69°C for 1 min., and extension at 72°C for 2 min. Every third cycle the annealing temperature
was reduced by 2°C until the temperature of 59°C was reached at which 30 cycles were
performed. A second variant of cycling was used which only differed by the annealing
temperatures. In this variant the temperature was lowered from 65°C to 55°C. All PCR-products
were analyzed by electrophoresis through 1% agarose gels. Some of the products were cut
out of the gel, eluted from the agarose using a gel-extraction kit (Quiagen Hilden, Netherlands)
and either subjected to restriction enzyme digestion or again used as template for PCR.
2.2.15 Reverse Transcription PCR (RT-PCR)
For analyses of RNA-transcripts an amplification of the material is often essential. Therefore
the RNA is converted into cDNA using the reverse transcriptase. This enzyme is a RNA-
depending DNA-polymerase synthesizing a complementary DNA from a RNA-template.
Commonly MMLV-RTase from the Moloney murine leukemia virus is used which lacks
RNase H-activity and has its optimal temperature at 42°C. In this study the SuperScriptTMII
reverse transcriptase was used.  Oligo (dT)12-18 primer were used to prime all RT-reactions to
select for the poly-A tails of mRNA.
RNA (1-5 µg) and 1µl of Oligo (dT)-primer were mixed in an Eppendorf tube, filled up to 12
µl with RNase-free water and incubated at 70°C for 10 min. to denature possible secondary
structures. After this step the tube was immediately placed on ice. 4 µl 5xRT-buffer, 1 µl
dNTPs and 2 µl DTT were added and the tube was incubated at 42°C for 2 min. followed by
the addition of 1 µl SuperScriptII to start the reverse transcription. Incubation at 42°C was
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the addition of 1 µl SuperScriptII to start the reverse transcription. Incubation at 42°C was
carried out for 1 h followed by 15 min. inactivation at 70°C. Depending on the expected
amount of transcribed cDNA, 1-5 µl of the reaction were used as a template in the PCR.
2.2.16 Restriction enzyme digestion
Digestion of PCR-products or genomic DNA was performed with restriction enzymes from
Boehringer, Mannheim, Germany and the corresponding buffers (composition of all restriction
enzyme buffers are listed in the Boehringer Catalogue 2000). Reactions were set up in 20
µl-scales as follows: 2 µl 10x restriction enzyme buffer, 2-10 µg DNA in 10 µl TE buffer, 1
µl enzyme, 7 µl destilled water. This reaction mix was incubated at 37°C for 2 h. The
products were analyzed by electrophoresis through 1% agarose gels.
Agarosegels for analyses of PCR-products or digestions were prepared as follows:
1g of agarose was dissolved in 100 ml 1xTBE-buffer by cooking in a microwave. After the
solution had cooled to 60°C, 4 µl ethidium bromide (10 mg/ml) were added and the gel was
poured immediately.
Mastermix for a 50µl-reaction Composition
10xPCR-buffer/-Mg++
10mM dNTPs
50mM MgCl2
DNA Taq-Polymerase
Template DNA
Primer each 10µM
destilled water
5			µl
1			µl
1.5µl
5			µl
2			µl
1µl each= 2µl
38	µl
End-concentration
1x
0.2	mM
1.5	mM
2.5 Units
each 0.2µM
dATP 100mM
dCTP	100mM
dGTP	100mM
dTTP	100mM
destilled water
10	µl
10	µl
10	µl
10	µl
60	µl
10	mM
10	mM
10	mM
10	mM
Desoxyribonucleotide-mix Composition End-concentration
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3 Results
3.1 A818-6 hollow sphere development analyzed by light microscopy
Under standard cell culture conditions, A818-6 cells grew as a monolayer culture (Fig. 8a)
with a doubling time of 69 h. When adherence of these cells to culture substratum was
prevented by coating tissue culture plates with solid agarose, hollow sphere development was
observed within a time frame of 10-14 days after the initial seeding. The development of
hollow spheres was subdivided into three phases: i) initiation ii) maturation and iii) senescence.
The phase of initiation proceeded from the day of seeding to day 6-8 of the development.
Signet-ring-like cells with an expanded vacuole (white arrows Fig. 8b) appeared. Six to eight
days after seeding, ”pre-mature” hollow spheres represented the predominant component of
the culture (Fig. 8c). Other remaining structures were identified as compact spheroids (black
arrow Fig. 8c) and signet-ring-like cells. The phase of maturation started after ”pre-mature”
hollow spheres were re-transferred into non-coated standard cell culture flasks. During the
next 4-6 days, hollow spheres became more homogenous in size and shape (Fig. 8d). In
comparison to earlier stages of the development, only few apoptotic cells were visible inside
the hollow spheres. In contrast to other remaining cell clusters, hollow spheres did not attach
to the surface of tissue culture grade flasks. Only after mechanical disruption or trypsinization
hollow sphere cells re-attached to the surface of the dish and grew again as a monolayer
culture (Fig. 8e). These ”re-monolayer” cells were able to develop new hollow spheres after
they were subjected to three-dimensional growth conditions again. The A818-6 system can
therefore be described as reversible. After more than three weeks in culture some A818-6
hollow spheres entered the phase of senescence. A high heterogeneity was observed when
hollow spheres became senescent. While some began to alter their phenotype after three
weeks, others remained unchanged for more than eight weeks and longer (Fig. 8f). In light
microscopy cells of hollow spheres which became senescent appeared more condensed (blue
arrow Fig. 8f). This process was observed for 2-3 days ending in a status of maximal
condensation (red arrow Fig. 8e).
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Figure 8
Fig.8: Analysis of A818-6 hollow sphere development by light microscopy. Panel a: A818-6 monolayer culture
under standard cell culture conditions. Panel b: Signet-ring-like cells of A818-6 after 1-2 days on solid agarose.
White arrows indicate typical cells. Panel c: A818-6 cells in three-dimensional culture after 5-6 days. Pre-mature
hollow spheres next to remaining compact spheroid-structures (black arrow). Panel d: Mature A818-6 hollow
spheres after 10-12 days in three-dimensional culture and re-transfer to uncoated cell culture plates. Panel e:
A818-6 cells growing as re-monolayer after mechanical disruption of a hollow sphere. Panel f: A818-6 hollow
spheres becoming senescent. The blue arrow indicates an early state, the red arrow the final state of the
senescence-process. Bars indicate 50 µm.
a b
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Next to suspension cultures, A818-6 cells were grown in semi-solid support like matrigel and
collagen I-gels. Embedded as monolayer cells they spread out and formed thin, tube-like
structures as previously shown for the subclone A818-1 (Lehnert et al., 1999). Embedded as
mature A818-6 hollow spheres they remained unchanged for more then two weeks (data not
shown).
3.2 A818-6 hollow sphere development  analyzed by electron microscopy
In electronmicroscopic analyses the initial step in hollow sphere development consisted of
the formation of cell clusters with multiple cell-cell contacts between neighboring cells (Fig.
9a). These cell clusters no longer had any cell-substratum adhesions but were held together
by multiple adherence junctions between A818-6 cells. Some of these cells contained large
vacuoles and an either central or lateral space within the cluster formed and dilated progressively.
In the next phase of development, mature hollow spheres were found abundantly now consisting
of a single cell layer (Fig. 9b) which was sealed towards the outside of the sphere by clearly
defined tight junctions between neighboring cells. No tight junctions sealing the internal
surface of hollow-sphere-forming cells were detected but lateral cell-cell contacts corresponded
ultrastructurally to adherence junctions. At the same time interval the plasmalemma facing
the outside of the sphere had developed an often dense and highly developed surface structure
of microvilli (Fig. 9c). During later phases of hollow sphere development occasional cell
death by apoptosis was found. Cells undergoing apoptosis were initially found in situ within
the single cell layer of hollow spheres still in contact with unaffected neighboring cells and
were then apparently sequestered to the lumen of the sphere as indicated by apoptotic or
partially digested cells in the sphere's lumen (Fig. 9d).
Overall, the hole process of A818-6 hollow sphere development was accompanied by a high
amount of apoptosis. Approximately 50% of the initially seeded cells underwent apoptosis
during the first two days of hollow sphere development.
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Figure 9
Fig. 9: Ultrastructural analyses at different stages of A818-6 hollow sphere development. After two days in
culture, clusters of A818-6 cells formed with multiple cell-cell contacts between neighboring cells (panel a, bar
=10 µm). Mature hollow spheres (10-12 days old) developed tight junctions (black arrow, panel b) and adherence
junctions constituting the polarized epithelial phenotype (white arrow, panel b). Bar =10 µm. Highly developed
microvilli were found on the apical surface of A818-6 hollow sphere cells being older than ten days (black
arrow, panel c). Bar = 2 µm. Cells with condensed chromatin but intact junctions to neighboring cells undergoing
apoptosis were observed throughout the entire hollow sphere development. These cells were sequestered to the
lumen of A818-6 hollow spheres (panel d) Bar =10µm.
a b
c d
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3.3 Proliferation
3.3.1 KiS5/KiS2-staining
Proliferation of hollow sphere- and monolayer cells was monitored by immunoperoxidase
staining for the proliferation-associated antigens Ki67 and p100 with the antibodies KiS5 and
KiS2. The Ki67 antigen is detectable in all phases of the cell cycle except in the G0-phase.
Therefore, cells being negative for Ki67 are arrested in the G0-phase of the cell cycle. The
p100 antigen is expressed in all phases of the cell cycle except G1/G0. KiS2-staining was
used to separate those KiS5-positive cells which are in the G1-phase of the cell cycle from
those being in S/M or G2. Based upon these data a distribution of A818-6 monolayer and
hollow sphere cell in the different phases of the cell cycle was evaluated and summarized in
table 2.  During hollow sphere formation a dramatic decrease in proliferation was observed.
While 95% of A818-6 monolayer cells were positive for Ki67, only 31.5% of A818-6 hollow
sphere cells were positive (Fig.10 a, b and table 2). This means approximately 70% of
A818-6 hollow sphere cells are arrested in the G0-phase of the cell cycle. Staining against the
p100 antigen with the monoclonal antibody KiS2 revealed that 23.3% of the Ki67-positive
cells in monolayer cells were in the G2/S-or M-phase while only 2.2% of hollow sphere cells
were found in these proliferative phases (Fig.10 c, d and table 2).
Results                                                                                                                 60
Figure 10 a
Figure 10 b
Fig.10 a and b: Results obtained by immunocytochemistry with the antibody KiS5 against Ki67 in A818-6
monolayer- and hollow sphere cells. Blue columns represent the amount of cell that were counted for the
evaluation of Ki67 positive cells (red columns) and negative cells (green columns). The averages of all evaluations
are indicated by (av.). The relation of averages is expressed in %.
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Figure 10 c
Figure 10 d
Fig.10 c and d:Results obtained by immunocytochemistry with the antibody KiS2 against p100 in A818-6
monolayer- and hollow sphere cells. Blue columns represent the amount of cell that were counted for the
evaluation of p100 positive cells (red columns) and negative cells (green columns). The averages of all evaluations
are indicated by (av.). The relation of averages is expressed in %.
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Table 2
Tab. 2: Distribution of A818-6 monolayer- and hollow sphere cells in the different phases of the cell cycle
determined by immunocytochemistry with the antibodies KiS5 and KiS2 against the proliferation associated
antigens Ki67 and p100.
3.3.2 Telomerase assay
A telomerase-assay was carried out as previously described (Klapper et al., 1998) using a
modified TRAP-assay. Recent publications showed a correlation between the status of
differentiation of cells and the telomerase activity  (Krupp et al., 1997). Therefore measurement
of telomerase activity can be used as a further indicator for differentiation in A818-6 hollow
sphere cells. In comparison to the corresponding monolayer, the relative telomerase activity
was found to be approximately six-fold reduced in hollow spheres (Fig.11).
Figure 11
Fig. 11: Comparison of the relative telomerase activity in A818-6 monolayer- and hollow sphere cells. Averages
(av.) and standard deviations are indicated.
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3.3.3 Analyses of cell cycle associated proteins
Further analyses on cell cycle associated proteins by Western blot analysis supported the
findings  observed by immunocytochemistry and telomerase-assay. The cell cycle is regulated
by interaction of promoting and inhibitory proteins. Growth arrest is often accompanied by
up-regulation of cell cycle inhibitors like p27Kip and p21/Cip and down-regulation of cell
cycle promotors like cyclin B. Consequently expression levels of these factors were analyzed.
The cell cycle inhibitor p27/Kip was expressed in larger amounts in hollow spheres than in
monolayer cells. The inverse result was obtained when the expression of the cell cycle
promotor cyclin B was compared between monolayer cells and hollow sphere cells (Fig.12
a). cyclin D1 (Fig. 12 c) was also detected in higher amounts in monolayer cells whereas
other cell cycle associated proteins like p21Cip (Fig.12 b) were found in equal amounts in
hollow sphere and monolayer cells or were not detected (table 3).
Figure 12
Fig.12: Western blot analysis of the expression of p27/Kip, cyclin B, cyclin D1 and p21Cip. Comparison
between A818-6 monolayer- (M) and hollow sphere (S) cells. Panel a: Unequal expression levels were observed
for cyclin B and p27 whereas cyclin D1 and p21Cip were expressed in equal amounts in A818-6 monolayer-and
hollow sphere cells (panel b).  Panel c: cyclin D1 slightly overexpressed in A818-6 monolayer cells compared to
the expression in hollow sphere cells. Proteins are indicated by arrows.
Tab..3: Expression of cell cycle associated proteins in A818-6 cells. Equal expression in monolayer- and 
hollow sphere cells is indicated by (eq.).
Expression levels of other cell cycle associated proteins
in A818-6 monolyer  and hollow sphere cells
protein expression
cyclin D3
cdc2
cdk2
cdk4
Rb
eq.
eq.
eq.
eq.
eq.
Table 3
66kD
46kD
cyclin B
S
30kD
21kD
p27Kip
β−actin
M
46kD
M S
p21Cip
30kD
46kD β−actin
cyclin D1
46kD
30kD
21kD
β−actin
b
c
a
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3.4 Expression of differentiation marker antigens
3.4.1 Expression of mucin-1
In normal ductal epithelial cells of the pancreas, highly glycosylated proteins of the mucin
family are facing towards the lumen of the duct. Subsequently the expression of mucin-1 was
analyzed in A818-6 cells. A818-6 hollow sphere cells expressed mucin-1 (MUC-1) antigen at
the outer surface being therefore identified as the apical membrane, which resembles the
lumen orientated membrane in pancreatic ducts in vitro (Fig. 13 a). A818-6 monolayer cell
exhibited a heterogeneous staining for MUC-1 with only single cells showing an apical
staining (Fig. 13 b).
Figure 13
Fig.13: Immunofluorescence staining of hollow sphere cells for duct cell differentiation marker antigens.
Mucin-1 staining depicts the apical membrane side of A818-6 hollow spheres (panel a). Heterogeneous staining
of mucin-1 in A818-6 monolayer cells (panel b). Analyses were performed using confocal laser scanning
microscopy. Bars indicate 10µm.
a b
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3.4.2 Expression of CD43
Leukosialin (CD43) is normally known to be expressed on cells of the hematopoietic system,
especially on immunocompetent cells. It is speculated, that one main function of CD43 is to
prevent cell contact between these cells (Manjunath et al., 1993). Recent works on CD43
showed expression on several tumor tissues as well (Santamaria et al., 1996). It may be
hypothesized tumors require the ability to express CD43 as a protection against cytotoxic
T-lymphocytes.
Testing this hypothesis immunofluorescence analyses were carried out with an antibody
against CD43, known to react positively with tumor tissues. Scraped A818-6 monolayer cells
were mixed with A818-6 hollow spheres and stained for CD43.  In Fig. 14 a, one hollow
sphere is surrounded by several monolayer cells as observed by light field microscopy. Fig.
14 b shows exactly the same observation field in epifluorescence. Only monolayer cells were
stained whereas A818-6 hollow sphere cells were negative (compare black arrows from panel
a with white arrows in panel b).
Figure 14
Fig.14: Comparison of CD43-expression between A818-6 monolayer- and hollow sphere cells. Both panels
represent the same observation field. In panel b the light was turned off and epifluorescence remained. Black
and white arrows indicate the identical cells in both panels. This experiment was analyzed by epifluorescence.
Bars indicate 10µm.
ba
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3.4.3 Expression of  β-catenin and E-cadherin
Between differentiated ductal epithelial cells, cell-adhesions are formed at the basolateral cell
surface. E-cadherin and β-catenin are the most important molecules in these adherence junctions.
In this study β-catenin exhibited a strictly lateral staining in A818-6 hollow sphere cells as
detected by confocal laser scanning microscopy (Fig. 15 a). This localization of β-catenin
correlated with the ultrastructural observations (compare Fig. 9, panel b). E-cadherin was
detected laterally  in A818-6 hollow spheres as well but did not exhibit such a clear staining
pattern than β-catenin (Fig.16 a). Furthermore α- and γ-catenin were found showing a weaker
but also laterally localized staining (data not shown). A818-6 monolayer cells revealed a
heterogeneous staining for both E-cadherin and β-catenin (Fig.15 b, 16 b).
Figure 15
Fig. 15: Detection of β-catenin in A818-6 hollow sphere cells (panel a) and monolayer cells (panel b) by
immunofluorescence. Analyses were performed using confocal laser scanning microscopy. Bars indicate 10 µm.
a b
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Figure 16
Fig. 16: Detection of Ε−cadherin in A818-6 hollow sphere cells (panel a) and monolayer cells (panel b) by
immunofluorescence. Analyses were performed using epifluorescence microscopy. Bars indicate 10µm.
3.4.4 Expression of other cell adhesion molecules
Beside cadherins and catenins, other molecules involved in cell adhesion were analyzed and
next to immunofluorescence-, Western blot experiments were carried out as a more quantitative
method for some antigens.
As shown by electron microscopy in Fig. 9 b, tight junctions were developed from A818-6
hollow sphere cells. Symplekin is a major molecule involved in the development of tight
junctions and stored in the nucleus of cells until it is needed. Subsequently symplekin was
analyzed in A818-6 cells and was found to be recruited to the membranes of A818-6 hollow
sphere cells during hollow sphere development while monolayer cells exclusively showed a
nuclear staining (Fig. 17 a, b).
a b
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Figure 17
Fig.17: Detection of symplekin in A818-6 hollow sphere cells (panel a) and monolayer cells (panel b) by
immunofluorescence. White arrows indicate the membrane recruited symplekin in A818-6 hollow sphere cells.
Analyses were performed using confocal laser scanning microscopy. Bars indicate 10µm.
In Western blot analyses performed for other cell adhesion molecules only paxillin showed a
quantitative difference between A818-6 monolayer- and hollow sphere cells (Fig.17) while
all others exhibited equal amounts in both phenotypes (table 4).
Figure 18
Fig.18: Western blot analysis for paxillin and focal adhesion kinase (FAK) in A818-6 monolayer (M)- and
hollow sphere (S) cells. Panel a: Upregulation for paxillin was found in A818-6 monolayer cells compared with
hollow spheres while an equal expression was observed for the focal adhesion kinase (panel b).
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actinβ−
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Table 4
Tab. 4: Expression of cell adhesion associated proteins in A818-6 cells. Equal expression in monolayer-
and hollow sphere cells is indicated by (eq.).
3.4.5 Expression of carbonic anhydrase II
As bicarbonate secretion of ductal epithelial cells is an important physiological feature,
carbonic anhydrase II (CAII) is a reliable marker for this type of cells. Reliable marker
antigens for acinar cells display the enzymes lipase and amylase. Consequently CAII was
detected in hollow sphere cells by indirect immunofluorescence staining (Fig.19) as well as
in the corresponding monolayer cells (data not shown). Immunocytochemistry with antibodies
against lipase and amylase were performed as controls and no reaction was observed.
Figure 19
Fig.19: Cytosolic staining for carbonic anhydrase II in A818-8
hollow sphere cells as assessed by immunofluorescence and confocal
laser scanning microscopy. Bar indicated 10µm.
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3.4.6 Expression of members of the carcinogenic embryonic antigen family
The carcinoembryonic antigen (CEA) is a tumor marker in serum of patients used in clinical
praxis to detect recurrence of a malignant disease. Tumor cells secrete CEA-180 as the
soluble form in an unpolar fashion. Immunhistochemically, A818-6 hollow spheres were
negative for CEA-180. In some cases single cells exhibited an apical staining being too weak
to be documented. Other members of the CEA-family like BGP and NCA 95 showed an
apical staining in hollow spheres and like CEA heterogeneous staining in monolayer cells.
Subsequently the secretion of CEA was measured in A818-6 cells with an automated ELISA
protocol for patient sera and A818-6 monolayer cells were found to secrete approximately
double amounts of CEA-180 than hollow sphere cells (table 5). For this experiment 100 and
200 hollow spheres containing approximately 200 cells were collected with a micromanipulator
(Eppendorf-Netheler-Hinz, Hamburg, Germany) and transferred into one well of a 24-well
plate. Cell culture medium was changed after 24 h followed by 48 h of incubation. Then the
supernatant was taken, centrifuged at 14,000 rpm to remove all cells and measured.
Corresponding monolayer cells reach confluency at the day of analyses and the number of
cells was counted after the supernatant was taken.
Calculation: 27,0000 ÷ 40,000 = 6.75 (relation between number of cells)
8.2 ng/ml ÷ 6.75 = 1.21 ng/ml
Equilibrated to the number of cells :
40,000 hollow sphere cells secrete 0.6 ng/ml CEA-180
40,000 monolayer cells secrete 1.21 ng/ml CEA-180
Secretion of CEA-180 in A818-6 monolyer  and hollow 
sphere cells
sample CEA-180 number of cells
100 hollow spheres
200 hollow spheres
A818-6 monolayer
RPMI1640
0.1 ng/ml
0.6 ng/ml
8.2 ng/ml
0.0 ng/ml
		20,000
		40,000
270,000
				0
Table 5
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3.5 Influence of cytokines and growth factors on A818-6 hollow sphere 
development
Hollow sphere development was found to be influenced by exogenously added cytokines.
Hollow sphere development was inhibited by Interferon-γ in a concentration dependend
manner. At a concentration of 20 U/ml, hollow spheres were able to develop but only in
reduced numbers. A concentration of 200 U/ml prevented hollow-sphere development, was
cytotoxic for mature hollow spheres and the corresponding monolayer (Tab. 6, 7). TNF-α
lead to cell death of monolayer- and hollow sphere cells at a concentration of 1000 U/ml.
TGF-β was found to prevent hollow sphere formation at a concentration of 10 ng/ml but had
neither influence on the integrity of mature hollow spheres nor on monolayer cells. All other
cytokines and growth factors tested, showed no visible influence on hollow sphere formation
over a period of 8 days. With exogenously added HGF/SF or Activin A, no visible changes in
hollow sphere development occurred. Neutralizing antibodies against HGF/SF and TGF-β
added to freshly seeded cells at a concentration of 1 µg/ml had no influence on hollow sphere
formation. From all cytokines and growth factors tested, only basic fibroblast growth factor
(bFGF) was able to stimulate growth and development of A818-6 hollow spheres. The
development was accelerated in speed and mature hollow spheres returned into a proliferative
state without loosing the highly differentiated phenotype.
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Tab.6: Cytokine treatment of A818-6 during hollow sphere development. Concentrations are indicated. Cell
culture medium containing cytokines and growth factors was replaced on day 2, 4 and 7. Standard hollow
spheres had a 100µm diameter.  Size assessments like larger/smaller refer to this standard size.
Cytokine Development of 
hollow spheres
Integrity of 
hollow spheres
Contr. 8-12 days standard
IFN-γ no influence smaller
IFN-γ inhibition no spheres
TGF-α no influence
EGF no influence
TNF-α cell death no spheres
HGF/SF no influence
no influence
no influence
no influence
Activin A no influence no influence
bFGF acceleration larger
TGF-β
Concentration
no cytokine
0.2-20 				U/ml
200 				U/ml	
		10				ng/ml
		10				ng/ml
1,000 				U/ml
100				ng/ml
2-8				ng/ml
5				ng/ml
		10				ng/ml no spheresinhibition
Influence of cytokines and growth facctors on A818-6 
hollow sphere development
Table 6
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Tab.7: Cytokine treatment of mature A818-6 hollow spheres. Concentrations are indicated.
Cell culture medium containing cytokines and growth factors was replaced on day 2, 4 and 7.
Standard hollow spheres had a100µm diameter.  Size assessments like larger/smaller
 refer to this standard size.
Next to TNF-α, an agonistic antibody to Fas-Ligand (ApoI) and the TRAIL-Factor were
tested for induction of apoptosis. A818-6 hollow spheres were found to be not sensitive for
both, ApoI at a concentration of up to 1 µg/ml or TRAIL at a concentration of 200 ng/ml or
500 ng/ml. Treated hollow spheres survived for more then 2 weeks without any sign of
apoptosis. The monolayer responded with few apoptotic cells after 72 h.
Cytokine Concentration Integrity of hollow spheres
control                  standard
IFN-γ                  smaller
IFN- γ                  no spheres
TGF-α                  no influence
EGF                  no influence
TNF-α                  no spheres
HGF/SF                  no influence
Table 7
 Influence of cytokines on mature hollow spheres
Activin A no influence
bFGF larger
TGF-β                  no influence
no cytokine
0.2-20 				U/ml
200 				U/ml	
		10				ng/ml
		10				ng/ml
1,000 				U/ml
100				ng/ml
2-8				ng/ml
5				ng/ml
		10				ng/ml
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3.6 Mesenchymal co-culture
3.6.1 A818-6 monolayer cells seeded on top of a confluent fibroblast monolayer
So far only bFGF was found to stimulate A818-6 hollow sphere development. Subsequently
the question was raised whether direct contact of A818-6 cells to mesenchymal cells may
stimulate hollow sphere development since it is known that mesenchymal support is a
prerequisite for proper development of lumenal structures in the pancreas.
Fibroblast co-cultures were carried out with A818-6 cells, foreskin-derived KIF-5-fibroblasts
and pancreas-derived PTF-994-fibroblasts. When A818-6 cells were seeded onto a confluent
fibroblast monolayer culture, invasive growth and the development of plaques of A818-6
tumor cells was detected (Fig. 20 a). When pre-mature A818-6 hollow spheres, shown in Fig.
19 b were seeded onto a confluent fibroblast monolayer culture, these hollow spheres increased
in size by increasing the number of cells per hollow sphere and developed a homogenous
shape within 48 h on both types of fibroblasts (Fig. 20 c, d).
Figure 20
Fig. 20: Co-culture with A818-6 cells, Kif5- and PTF994-fibroblasts. Arrows in panel a indicate invasive
plaques of A818-6 monolayer cells. Panel c: Pre-mature hollow spheres after 48 h of culture on top of
Kif5-fibroblasts. Panel d: Pre-mature hollow spheres after 48 h of culture PTF994-fibroblasts. Bars indicate
100 µm.
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ba
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3.6.2 A818-6 cells in suspension  co-culture with fibroblasts
In a second experimental set up, A818-6 monolayer cells were mixed with fibroblasts and
seeded on agarose-coated dishes. This procedure was also found to enhance A818-6 hollow
sphere development. Two days after initial co-culture of A818-6 cells with KIF-5-fibroblasts
development of hollow spheres was seen, which was normally observed after 6-8 days in
cultures without fibroblasts (Fig. 21 a) Some of these hollow spheres already contained more
than 150 cells. Later ”giant-spheres” with an diameter of up to 500 µm developed. Remarkably
a different result was obtained with pancreas-derived PTF994-fibroblasts. The size of the
developing hollow spheres was standard but the total amount of hollow spheres was increased
in co-culture with PTF994 (Fig. 21 b). In accordance with Kif5-results the speed of hollow
sphere development was increased as well.
Figure21
Fig.21: Suspension co-culture with A818-6 cells, Kif5 and after of co-seeding on solid agarose. Panel a:
A818-6 cells with development of “giant-spheres”. Panel b: A818-6 cells seeded with development of an
increased number of hollow spheres. Bars indicate 100µm.
The same experiment was repeated with EGFP-transduced fibroblasts exhibiting a green
fluorescence when exposed to UV-light and revealed a localization of fibroblasts in the
lumen of hollow spheres closely associated to the basal side of A818-6 cells (Fig 22 a-d).
Fibroblast-conditioned medium was not able to replace the direct presence of fibroblasts
in the same manner (data not shown).
ba
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Figure 22
Fig. 22: Confocal laser scanning analysis of co-culture experiments of A818-6 cells with Kif-5 fibroblasts
transduced with the gene coding for the enhanced green fluorescent protein (EGFP). After six days of
hollow sphere development, A818-6 cells were stained for the mucin-1 antigen. Mucin-1 displayed a
staining of apical membranes of A818-6 hollow sphere cells (panel a). Fibroblasts are depicted by EGFP-
derived fluorescence (panel b). Panel c displays a differential interference contrast image of the analyzed
hollow sphere with fibroblasts closely associated with the basal side of hollow sphere cells (yellow arrow
and panel c and d) accompanied by  a putative sequestered, non-fluorescing single A818-6 cell (black arrow
panel c and d). Bars indicate 10 µm.
3.6.3 Influence on cell cycle associated proteins
Analysis of the cell cycle associated proteins cyclin B and p27/Kip after co-culture revealed a
downregulation of p27/Kip and a weak upregulation of cyclin B in A818-6 hollow spheres
which were seeded on top of fibroblast monolayers (Fig. 23), underlining the observations
made at the microscopic level (compare Fig. 20 c, d).
a b
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Figure 23
Fig.23: Regulation of p27Kip and cyclin B in A818-6 cells under mesenchymal influence analyzed by
Western blot analysis. A818-6 hollow spheres without Kif-5 co-culture (S) exhibited a lower expression of
cyclin B and an increased expression of p27/Kip compared to the corresponding monolayer (M). In hollow
spheres seeded onto fibroblasts (S+F), the expression of p27 was downregulated and the expression of
cyclin B was slightly upregulated compared to hollow spheres without co-cultured fibroblasts. Lanes M and
S are equivalent with Fig.12, panel a.
3.6.4 Growth of A818-6 cells on pre-formed fibroblast-spheroids
A third co-culture model was set up to optimize contact between tumor cells and fibroblasts
after it was observed that fibroblasts attached to the basal side of A818-6 hollow spheres. Kif
5-EGFP-fibroblasts were seeded onto solid agarose and formed compact spheroids (Fig. 24
a). The following day, A818-6 cells were seeded into the well containing fibroblast-spheroids.
During the following three days A818-6 cells attached to the fibroblast-spheroids and grew
around them as a single layer epithelium (Fig. 24 b, c). These complex structures were called
”fibro spheres”.
Figure 24
Fig.24: Culture of A818-6 cells on pre-formed fibroblast spheroids.  Panel a: Kif-5 spheroid 24 h after
seeding onto solid agarose. Panel b: Epifluorescence of EGFP-transduced fibroblast spheroids. Panel c:
Phase-contrast/ Epifluorescence overlay showing fibroblast spheroids from panel b surrounded by A818-6
cells. Bars indicate 100µm.
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Approximately 50% of all fibroblast-cores were surrounded by a single layer of A818-6 cell
while others showed multilayers of A818-6 cells. In these structures the epithelial cells lost
their direct contact to the fibroblast core (data not shown).
To assure the single layer character of A818-6 cells surrounding the fibroblast-cores
immunocytochemical staining for β-catenin was carried out. A818-6 cells were found to be
organized in a polar fashion with their basal side attaching to the fibroblast-core  as assessed
by confocal laser scanning microscopy  (Fig. 25 a-d).
Figure 25
Fig. 25: Confocal laser scanning analysis of co-culture experiments of A818-6 cells grown on Kif-5 fibroblasts
transduced with the gene coding for the enhanced green fluorescent protein (EGFP). After six days of fibro
sphere development, A818-6 cells were stained for the β-catenin antigen. Beta-catenin displayed a staining
of basolateral membranes of A818-6 cells (panel b, c). Fibroblasts are depicted by EGFP-derived fluorescence
(panel a, d). Panel c displays a differential interference contrast image of the analyzed fibro sphere. Black
and white arrows in panel b and d indicate a typically polarized A818-6 cell as part of a hollow sphere
which surrounds a fibroblast-core. Bars indicate 100 µm.
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Investigations on the development of an extracellular matrix as a product of both tumor-
and mesenchymal cells revealed that fibroblasts produced fibronectin (Fig. 26 a-d). A818-6
hollow sphere cells were found to produce and secrete laminin at their basement membranes.
While only a low expression of laminin was detected in hollow spheres developed without
mesenchymal core (Fig. 27), laminin was induced as a direct reaction to the co-culture
with fibroblast spheroids (Fig. 28 a-d).
Figure 26
Fig. 26: Confocal laser scanning analysis of co-culture experiments of A818-6 cells grown on Kif-5 fibroblasts
transduced with the gene coding for the enhanced green fluorescent protein (EGFP). After six days of fibro
sphere development, fibroblasts were stained for the fibronectin antigen. Fibronectin displayed a mainly
cytosolic staining in fibroblasts (panel b, d). Fibroblasts are depicted by EGFP-derived fluorescence (panel
a, d). Panel c displays a differential interference contrast image of the analyzed fibro sphere. The black
arrow in panel d indicates the boarder between polarized A818-6 cells and the fibroblast core. Bars indicate
100 µm.
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Figure 27
Fig. 27: Confocal laser scanning analysis of A818-6 hollow spheres stained against laminin. Laminin
displays a weak but basal staining in A818-6 hollow sphere cells (black and white arrows). Bars indicates
10 µm.
Figure 28
Fig. 28: Confocal laser scanning analysis of co-culture experiments of A818-6 cells grown on Kif-5 fibroblasts
transduced with the gene coding for the enhanced green fluorescent protein (EGFP). After six days of fibro
sphere development, fibroblasts were stained with an antibody against laminin. Laminin is mainly expressed
form A818-6 cells at the boarder between epithelial and mesenchymal cells (white arrows panel c) but also
from fibroblasts (white arrows panel d). Fibroblasts are depicted by EGFP-derived fluorescence (panel b, c).
Panel a displays a differential interference contrast image of the analyzed fibro sphere. Bars indicate
100µm.
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100µm.
3.6.5 The role of epimorphin
Epimorphin was recently described as a mesenchymal factor modulating morphogenesis
of murine mammary ducts, skin, liver and lung in vitro. Hirai and co-workers (1998)
showed that a monoclonal antibody to epimorphin was able to prevent the development of
lumenal structures in murine mammary epithelial cell. This finding suggested to analyze
the role of epimorphin in the A818-6 system. A rat-monoclonal antibody MC-1 was
previously described to react with native epimorphin (Hirai, 1993; Hirai et al., 1993) and
was able to inhibit branching morphogenesis in mammary duct cells (Hirai et al., 1998).
3.6.5.1 Inhibition of A818-6 hollow sphere development by a monoclonal antibody  
(MC-1) against epimorphin
Incubation of freshly seeded A818-6 cells with 50 µg/ml of MC-1 under three-dimensional
culture conditions resulted in the inhibition of A818-6 hollow sphere development (Fig. 29
a-b). A rat IgG-isotype control for human IL-13 as control (50 µg/ml) showed no effect on
A818-6 hollow sphere development (Fig. 29 c). So far, it has been generally assumed that
fibroblasts are essential for the mediation of an epimorphin effect by a 150kDa form, associated
to the membrane of fibroblasts. However, in this experiment an epimorphin effect independent
of the presence of fibroblasts was found in A818-6 cultures. Therefore, epimorphin must act
as a soluble factor in an autocrine manner in the A818-6 system. Neither a neutralizing
antibody against HGF/SF nor recombinant HGF/SF added to freshly seeded cells had influence
on hollow sphere formation even though HGF/SF and its receptor c-met were detected in
A818-6 monolayer and hollow sphere cells by immunocytochemistry with intense staining
for the receptor and only faint staining for the ligand (data not shown). Exogenously added
recombinant epimorphin (31kDa-isoform) was not able to induce lumenal structures in A818-4
cells lacking epimorphin expression so far.
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Figure 29
Fig. 29: Inhibitory influence of a monoclonal antibody against epimorphin, MC-1 on A818-6 hollow sphere
development. A818-6 cells were cultured on solid agarose for eight days in the presence of MC-1 (50
µg/ml) (panel a). A818-6 cells cultured on solid agarose for eight days without MC-1 (panel b). A818-6
cells cultured on solid agarose for eight days in the presence of an antibody against human IL-13 used as an
isotype control (panel c). The antibodies were added on day 2, 5 and 7 after seeding. Bars indicate 50 µm.
3.6.5.2 Expression pattern in cell lysates of A818-6 monolayer cells, A818-6 hollow 
sphere cells and fibroblasts
All forms of epimorphin previously described by others were detected with an affinity-purified
antibody against epimorphin as assessed by Western blot analyses (Fig. 30 a, b). The 150kDa-
tetramer of epimorphin was only detected in the lysates of fibroblasts (Fig. 30 b) whereas it
was not detectable by Western blot analysis in lysates of A818-6 monolayer- and hollow
sphere cells. No difference in the expression pattern of 70kDA-dimers was observed when
fibroblasts, A818-6 monolayer cells and A818-6 hollow sphere cells were compared.
Differences were observed in the expression pattern of monomeric 34kDa- and 31kDa-isoforms
of epimorphin. Both isoforms were expressed in A818-6 monolayer cells while three-
dimensional hollow spheres exclusively expressed the larger 34kDa-isoforms. Fibroblasts
expressed larger amounts of the smaller, 31kDa-isoform, than of the 34kDa-isoforms (Fig. 30
a b
c
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expressed larger amounts of the smaller, 31kDa-isoform, than of the 34kDa-isoforms (Fig. 30
a). Subsequently, cell lines not developing lumenal structures were compared with cell lines,
growing with a lumenal phenotype under our cell culture conditions. Here it was observed
that all cell lines capable of lumen-formation expressed the larger 34kDa-isoforms of epimorphin
occasionally together with the 31kDa-isoform. Cell lines not capable of lumen-formation
expressed only the smaller 31kDa-isoform or none (Fig. 30 c). The cell lines Capan-2 and
BxPC-3 that expressed the 34kDa-isoforms responded upon fibroblast co-culture with
stimulation of the development of lumenal structures. Cell lines only expressing the 31kDa-
isoform or none (Capan-1, A818-4, Panc 1) showed no induction of lumen-formation in
fibroblast co-culture (data not shown).
Figure 30
Fig. 30: Detection of epimorphin in protein lysates of pancreatic carcinoma cell lines and fibroblasts. Panel
a: Western blot analyses of epimorphin in protein lysates of A818-6 monolayer cells (M), hollow sphere
cells (S) and Kif-5 fibroblasts (F). Monolayer cells expressed the 34kDa- and 31kDa-isoforms while hollow
sphere cells lacked the 31kDa-isoforms. Fibroblasts expressed larger amounts of the 31kDa-isoforms of
epimorphin than of the 34 kDa-isoform (a, lane F). Panel b: The 150kDa tetrameric complex, 70kDa dimer
and monomers of epimorphin detected in the lysate of Kif-5 fibroblasts. To make the tetrameric form
visible a long exposure time was used which prevents visualization of the monomeric isoforms as two
bands. Panel c: Western blot analysis of epimorphin in protein lysates of the pancreatic carcinoma cell lines
Capan-1 (C1) Capan-2 (C2), A818-4 (A4), Panc-1 (P1), BxPC-3 (Bx) and A818-6 hollow sphere cells (S)
as control also taken as negative control by omitting the primary antibody (Neg). All cell lines being
capable of lumen-formation (A818-6, Capan-2, BxPC-3) expressed the 34kD-isoform of epimorphin
occasionally together with the 31kD-isoform. Cell lines not developing lumenal structures (Capan-1, A818-4,
Panc1) expressed no epimorphin or only the 31kDa-isoforms. Epimorphin isoforms are indicated by arrows.
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3.6.5.3 Detection of soluble epimorphin in supernatants of A818-6 hollow spheres, 
fibroblasts and co-cultures of both
Supernatants of A818-6 cells and fibroblasts were analyzed for putative soluble forms of
epimorphin. Immunoprecipitations followed by Western blot analyses were carried out
with the monoclonal MC-1 antibody and an affinity purified polyclonal antibody against
epimorphin. First is was essential to prove that MC-1 detects the same antigens in the
immunoprecipitate of the affinity purified antibody and vice versa. Supernatants from
fibroblasts were used as source and both antibodies were found to detect the same antigens
(Fig. 31a). Subsequently it was found that both antibodies were able to detect the monomeric
34kDa- and 31kDa-isoforms of epimorphin and the dimeric form of approximately 70kDA
in the supernatants of A818-6 hollow spheres, Kif-5 fibroblasts and co-cultures from
fibroblasts and hollow spheres. No tetrameric complex of 150kDa was detected in any of
the supernatants. Epimorphin was neither found in the pure cell culture medium nor
detected in the precipitate of an anti-human IL-13 (rat-IgG) antibody used as control (Fig.
31b).
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Figure 31
Fig. 31:  Detection of epimorphin in the supernatants of A818-6 hollow spheres and Kif-5 fibroblasts by
immunoprecipitation with the monoclonal antibody MC-1 and an affinity purified polyclonal antibody
against epimorphin.
Panel a: Western blot analysis following immunoprecipitation from fibroblast (Kif-5) supernatants to confirm
the detection of the same antigen (human epimorphin) by both antibodies used under these conditions. In
lane 1 the precipitate obtained with the monoclonal antibody MC-1 was probed with the polyclonal rabbit
serum against epimorphin, affinity purified against recombinant epimorphin. In lane 2, the precipitate
obtained with the affinity-purified antibody was probed with the monoclonal rat-IgG- antibody against
epimorphin MC-1. Epimorphin isoforms and dimers are indicated by arrows. Panel b: Western blot analysis
following immunoprecipitation from A818-6 hollow sphere supernatants, Kif-5-fibroblast supernatants and
supernatants obtained from co-cultures (pre-mature hollow spheres and fibroblasts). Precipitates obtained
with both antibodies (MC-1 and the affinity purified polyclonal antibody against epimorphin) were resolved
by SDS-PAGE (15%) and transferred to a nitrocellulose membrane. In lane 1, epimorphin was precipitated
from hollow sphere supernatant by MC-1 and detected by MC-1. In lane 2 epimorphin was precipitated
from hollow sphere supernatant and detected by the affinity purified polyclonal antibody. Epimorphin was
also precipitated and detected by the affinity purified polyclonal antibody from co-culture supernatants
(lane 3) and fibroblast supernatants (lane 4). In lane 5 an anti-human IL-13 (rat-IgG) antibody was used for
precipitation from hollow sphere supernatants. This precipitate was probed with MC-1 on the succeeding
Western blot (negative control). Epimorphin isoforms and dimers of the monomers are indicated by arrows.
3.6.5.4 Detection of epimorphin mRNA
On the mRNA level epimorphin was detected by RT-PCR in A818-6 monolayer- and hollow
sphere cells (Fig. 32). Due to primer design the expected fragment size for epimorphin was
446bp. The most prominent band in Fig. 32 was found to exhibit the expected size. The
upper, prominent band was cut out to prove the amplification of correct epimorphin-fragment.
The DNA was eluted from the gel and digested with the restriction enzyme ClaI which
should produce two fragments of 301bp and 145bp in case of the correct amplicon. As shown
in Fig. 32 these fragments were obtained after the digestion with ClaI.
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in Fig. 32 these fragments were obtained after the digestion with ClaI.
Figure 32
Fig. 32: RT-PCR for human epimorphin from RNA samples of A818-6 monolayer cells (M) and hollow
sphere cells (S). The upper band of 446 bp was excised from the gel and used as probe (P) in a digest with
the restriction enzyme ClaI (D). Fragment sizes are indicated as determined with a 100bp-DNA ladded (L)
as standard.
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4 Discussion
4.1 Discussion of methods
4.1.1 Generation of A818-6 hollow spheres
Epithelial cells have been cultured under various conditions and in most of the cases the
two-dimensional monolayer-cell culture was the method of choice. Advantages of monolayer
cultures with tumor cells are a quick access to mass production of cells and a high reproducibility
of experiments due to the standardized culture conditions. On the other hand one must keep
in mind that monolayer cultures are the most artificial cell culture type because under
physiological conditions all cells are embedded in three-dimensional environment and this
environment is essential for the regulation of growth and differentiation (Hollingsworth,
1999).  Therefore experiments carried out in monolayer cultures gain performance by selling
expressiveness. To overcome this discrepancy, researches thought about three-dimensional
cell culture types coming closer to the in vivo situation with a high reproducibility and a good
performance with Holtfreter and co-workers as pioneers (Holtfreter, 1944).
Basic work on morphology with three-dimensionally grown, multicellular aggregates was
done during the 50ies and 60ies (Halpern et al., 1966; Moscona, 1952) until Inch and co-workers
began to utilize aggregates to study the response of cell aggregates to radiotherapy in the
early 70ies (Inch et al., 1970). They coined the term ”multicellular spheroids”. Since cell
survival curves were similar in radiation experiments either with aggregates or with solid
tumors, multicellular spheroids were henceforth considered in vitro tumor models for mimicking
basic biological properties of cancer cells in vivo. Through their fundamental investigations
Inch and associates inaugurated a continuously increasing number of studies on cell aggregates
in various fields of experimental cancer research (Chuang and Liao, 2000; Graff et al., 2000;
Quarrie et al., 1999).
Beside the support of cells with microcarriers or sponges one basic principle of three-dimensional
suspension cell culture is to prevent the adherence of cells to substratum. This may either be
achieved by stirring cells around in liquid media using so called ”spinner-flasks” (Inch et al.,
1970) or by coating cell culture flasks with non-adhesive material like agarose. Instead of
coating flasks of cell culture grade, culture flasks of microbiological grade were used which
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coating flasks of cell culture grade, culture flasks of microbiological grade were used which
also reduced adherence. However, it has to be considered that depending on the way three-
dimensional structures are generated, experimental outcomes may be altered. In cultures of
A818-6 cells on solid agarose for example approximately 50% of the cells underwent apoptosis
during hollow sphere development. If culture flasks of microbiological grade were used,
some cells attached to the surface and grew out as monolayers, not becoming apoptotic. In
these cultures the ratio between apoptotic cells and hollow sphere-developing cells was
altered already by changing the way adhesion was prevented. If the coating-method was used
to generate A818-6 hollow spheres, it was further important how much agarose was poured
into each well. The more agarose was poured, the more concave the coating layer became due
to the adhesion of agarose to the walls of the well.
This concave coating layers forced cells to role to the middle of the plate. A higher density
of cells in the middle of the plate resulted in a higher amount of compact spheroids instead of
hollow spheres.
Subsequently, the cell density was another important factor which has been standardized
during many experiments. Less than 1x105 cells seeded per well of a 6-well plate were
insufficient to produce enough hollow spheres for the experiments while more than 5x105
cells aggregated to large spheroid-like complexes leaving only few cells which developed
into hollow spheres during 8-10 days. However, even under high density conditions hollow
spheres developed from spheroid-like structures building ”hollow buds” which were released.
In contrast to  normal hollow sphere development this procedure needed additional two
weeks. Closely associated with the problem of aggregation to complex spheroids was the
time of trypsinization of A818-6 cell prior to subjecting them to suspension culture. Grown as
monolayer cultures these cells exhibited a strong affinity to substratum and needed significantly
longer to be removed from the plates by trypsin/EDTA than other pancreatic carcinoma cell
lines like Capan-2 or Panc-1. An average time of 30 min. was found to exhibit the best results
with respect to the hollow sphere outcome. Shorter times lead to stronger aggregation of cells
to spheroid-like structures while longer times lead to smaller hollow spheres. These observations
suggest a critical role for integrins and cadherins as important molecules in either cell-cell
adhesion or cell-matrix adhesion (Takeichi, 1993; Stallmach et al., 1991).  The shorter the
Discussion                                                                                                         89
adhesion or cell-matrix adhesion (Takeichi, 1993; Stallmach et al., 1991).  The shorter the
trypsin-incubation time, the more adhesion molecules remain on the cell surfaces which may
allow cells to quickly accumulate to spheroid-structures of under three-dimensional growth
conditions whereas longer trypsin-incubation may lead to loss of most adhesion molecules
and a therefore less efficient hollow sphere formation.
A818-6 cells subjected to a rotation culture (InVitro, Mannheim, Germany) also developed
hollow spheres but smaller ones. However, hollow sphere development was observed under
all tested conditions and conditions described in Material and Methods are optimized for high
amounts of hollow spheres.
A high purity of hollow sphere cultures was essential to investigate differences between
A818-6 hollow sphere- and monolayer cells. As mentioned before, approximately 50% of the
initially seeded cells underwent apoptosis during hollow sphere development. It was impossible
to remove all cell debris by standard centrifugation methods. Additionally proteins from dead
cells contaminated the culture medium leading to false results in Western blot analyses for
example.
Therefore a glass capillary adjusted to a micromanipulator was used to collect hollow spheres
needed for an experiment.
4.1.2 Co-culture methods
Two basic co-culture methods were used in this study. The first was to mix two cell populations
in equal amounts and to seed them together into pre-coated wells. The second was to pre-culture
fibroblasts as confluent monolayers and to seed either trypsinated A818-6 cells or pre-mature
hollow spheres on top of them.
In all co-culture experiments with two cell populations having different medium-requirements
it is a prerequisite to define cell culture conditions both populations are satisfied with. In the
case of fibroblast medium it was important to consider the influence of basic fibroblast
growth factor onto hollow sphere development (compare 3.6.1, Results) and even not tested
in detail, insulin as part of fibroblast medium might have an influence on A818-6 cells as
well. Therefore RPMI1640 was used in all co-culture experiments. Experiments using the
first variant of co-culture methods were only performed for the investigation of events that
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first variant of co-culture methods were only performed for the investigation of events that
could have been analyzed by microscopy including changes in shape or size of hollow
spheres or differences in the speed of hollow sphere development. Once mixed, it was not
possible to separate mesenchymal from epithelial cells to obtain protein-lysates or RNA-samples
form only one cell type. Therefore Western blot analyses e.g. with fibroblast-stimulated
A818-6 cells were only performed with hollow spheres being seeded on top of fibroblasts
from were they could be easily removed without fibroblasts.
Co-culture experiments became much easier after EGFP-transduced fibroblasts were used.
Unfortunately, pancreas-derived fibroblasts showed only unsatisfying fluorescence after EGFP-
transduction. So far, no success was achieved in establishing a pancreas derived fibroblast
cell line with satisfying EGFP-fluorescence. Skin-derived fibroblasts showed a satisfying
fluorescence and were therefore used for most of the experiments. However it has been
described that fibroblasts from different organs have a different influence on tumor cells
(Okumura et al., 1992). Therefore it is essential to proceed the work of A818-6 co-cultures
with organ-derived fibroblasts like PTF994 in the future.
4.1.3 Immunocytochemistry
First immunocytological experiments with A818-6 cells were performed by collecting
monolayer- and hollow sphere cells by spinning them onto microscopic slides followed by
staining as described in 2.2.4.1. This procedure worked well with monolayer cells but hollow
spheres were lost during the multiple washing steps. From 100 hollow spheres collected on a
microscopic slide 5 to 10 remained after the entire staining process. Even different coating
agents like poly-L-lysin or chicken-albumin did not improve this method. Subsequently the
only experiments performed with cytospins were stainings for the proliferation associated
antigens Ki67 and p100 by using approximately 1,000 hollow spheres per slide from which
80-100 remained after the entire staining process. All other immunocytochemical experiments
were carried out with cells stained in suspension (see 2.2.4.2, Methods) because staining on
slides caused a waste of material. This staining procedure was especially adapted to A818-6
hollow spheres and permitted to maintain the three-dimensional shape of A818-6 hollow
spheres throughout the hole process. For microscopical investigation coverslips were placed
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spheres throughout the hole process. For microscopical investigation coverslips were placed
on small wax-clumps allowing hollow spheres to remain three-dimensional even under
microscopic conditions.  This staining method worked well for membrane associated and
nuclear antigens whereas cytosolic antigens sometimes lead to an eclipse of fluorescence
caused by at least two cell layers above each other making it difficult to determine exact
staining patterns. The disadvantage of the method was that monolayer cells were cept in
suspension, floating around. Another critical point was the ”trapping” of the antibodies in the
lumen of hollow spheres after they were permeabilized for staining of cytosolic or nuclear
antigens. In most cases excessive washing with PBS overnight solved that problem. In some
cases it was possible to determine the specificity of an antibody-reaction by analyzing the
experiments with a laser scanning microscope. The unspecific binding (trapping) of the
secondary antibody in the negative control was substracted from the sample by closing the
pinhole of the laser. Only fluorescence brighter than the background remained and was
attributed to a specific reaction of the primary antibody.
Taken together the cultivation and staining of A818-6 hollow spheres was standardized to
permit reproducibility and comparability of all experiments.
4.2 Discussion of results
4.2.1 A818-6 hollow sphere development
As mentioned before, the three-dimensional culture of A818-6 hollow spheres must be seen
in the tradition of earlier spheroid-cultures which resembled in vitro tumors. In contrast to
these tumor models, the A818-6 systems displays a differentiation model using a pancreatic
adenocarcinoma cell line which is able to revert the malignant into a partially benign phenotype.
So far only one other comparable model system was described for the human pancreas also
taking advantage of a highly differentiated adenocarcinoma cell line, Capan-1. Hollande and
co-workers described a similar phenomenon for this cell line as it was described here for
A818-6. However, Capan-1 cells were tested under culture conditions of A818-6 cells and
did not display a lumenal phenotype. Additionally  Capan-1 ”hollow spheroids” mostly
consisted of more than a single layer of epithelial cell building the described phenotype
(Hollande et al., 1998; Hollande et al., 1990). For other cell types  and cells from other
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(Hollande et al., 1998; Hollande et al., 1990). For other cell types  and cells from other
species lumen-formation is well described. Experiments with Mardin-Darby canine kidney
(MDCK) cells and a colon carcinoma cell line (LIM 1863) suggest a mechanism for the
development of lumenal structures from epithelial cells. MDCK cells were described to form
tubular structures when grown in three-dimensional collagen gels (McAteer et al., 1986) and
share the phenomenon of ”clutching” with LIM1863 cells (Lincz et al., 1997). On the
ultrastructural level clutching is characterized by the encapsulation of one epithelial cell by
another as a very early step in the process of lumen-formation. A818-6 cells exhibited
comparable stages relatively early in hollow sphere development (compare Results Fig. 9 a)
but did not always show a complete encapsulation of cells. This finding is in accordance with
MDCK cells which also do not display a complete encapsulation but are able to form lumenal
structures (Lincz et al., 1997).  Clutching allows direct communication between cells to
facilitate proper orientation and can also be regarded as a sign of differentiation; as the
transitional state between a group of unpolarized cells and the formation of a highly organized
three-dimensional structure.
A different hypothesis about how A818-6 hollow spheres start their development is to postulate
a single cell as progenitor. Especially ”signet-ring-like” cells as a characteristic phenotype in
an early stage of hollow sphere development may bear this function. However, the detailed
mechanism of A818-6 hollow sphere development will only be unraveled by an extended
ultrastructural analysis combined with an on-line documentation as performed for LIM 1863
cells (Lincz et al., 1997). Unless these studies have not been performed the model described
for LIM 1863 and MDCK cells is taken as the most likely one for A818-6 hollow sphere
development as well. During A818-6 hollow sphere development approximately 50% of the
initially seeded cells developed a lumenal phenotype while most other cells underwent apoptosis
or aggregated in spheroid-like structures. Therefore one might consider A818-6 hollow sphere
cells as a subpopulation of the A818-6 cell line. On the other hand not all cells from a
re-monolayer (monolayer which grew out after mechanical disruption of one hollow sphere)
were able to generate new hollow spheres suggesting a regulative process turned on under
special circumstances like contact inhibition (Soriano et al., 2000; Rashid and Basson, 1996).
The aspect of contact inhibition is of particular interest with regard to the upregulation of the
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The aspect of contact inhibition is of particular interest with regard to the upregulation of the
cell cycle inhibitor p27/Kip found during hollow sphere development. Involvement of p27/Kip
into epithel-cell-differentiation has been described in general (Lloyd et al., 1999) and in
association with E-cadherin (St. Croix et al., 1998). However, the question arised whether
A818-6 hollow sphere cells represent the ”most benign” phenotype of the A818-6 system.
When  normal epithelial cells are either detached from their neighboring cell or their substrate,
they undergo ”anoikis” (apoptosis after detachment) (Frisch, 1999). Approximately 50% of
A818-6 also not ”survive” the detachment from their substrate. Since it has been described
that β-catenin dysregulation leads to resistance against anoikes (Orford et al., 1999), it will be
interesting to further analyze the regulation of β-catenin in the A818-6 system.
4.2.2 Development of junctional complexes
Loss of E-cadherin (Perl et al., 1998; Bracke et al., 1997) and changes in the expression of
catenins (Sparks et al., 1998; Hague et al., 1997) displaying major components of adherence
junctions, generally lead to a loss of contact inhibition, can change the tissue integrity and
were described to be crucial for the development of a variety of malignant progressions.
Especially the staining pattern for β-catenin in hollow spheres confirmed the identification of
lateral adherence junctions at the electronmicroscopical level and underlines the strictly polar
orientation of A818-6 cells in hollow spheres. A818-6 monolayer cells exhibited a heterogeneous
staining pattern for cadherins and catenins. These findings are in accordance with the role of
p27/Kip as an important indicator for differentiation in this system. Adherence junctions were
the first cell-cell contacts recognized in A818-6 hollow sphere development as assessed by
electron microscopy and according to the phenomenon of ”clutching” (Lincz et al., 1997)
they were found sporadically distributed. The anchorage of actin skeletons of cells are a
prerequisite for the development of a proper cell polarity and the important role of cadherins
and catenins in this context has been studied in Drosophila melanogaster previously (Grawe
et al., 1996).
Mature A818-6 hollow spheres were ultrastructurally characterized by well-developed
microvilli covering their apical membranes which were sealed by tight junctions further
denoting the polarized epithelial development. Microvilli and tight junctions are characteristic
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denoting the polarized epithelial development. Microvilli and tight junctions are characteristic
features of normal duct epithelial cells of the pancreas (Gumbiner, 1987; Stevenson and
Keon, 1998). Additionally,  the process of tight junction formation was found accompanied
by translocation of symplekin from the nucleus to the membrane of A818-6 hollow sphere
cells. This recruitment was not observed in monolayer cells. Recruitment seems to be a
general mechanism for tight junction proteins which are stored somewhere else in the cell
and then transported to the place they are needed (Yap et al., 1995). As the development of
tight junctions reflects a high degree of differentiation the recruitment of a major component
of the ”zonula occludens”, symplekin, underlines the process of increasing differentiation of
A818-6 cells during hollow sphere formation (Keon et al., 1996).
4.2.3 Polarity of A818-6 hollow sphere cells
It still remains unclear why A818-6 hollow spheres exhibit a polarity with the apical membranes
facing towards the surrounding cell culture medium as shown by various results including
those from immunostaining with antibodies against mucin-1 and β-catenin.  A similar orientation
of cells was described for the pancreatic adenocarcinoma cell line Capan-1 also forming so
called ”hollow spheroids” (Fanjul and Hollande, 1993). These cells exhibited an inverted
polarity after a Capan-1 tumor was heterotransplanted into nude mice (Murat et al., 1989)
which was explained by the presence of extracellular matrix produced by fibroblasts of the
connective tissue of the mouse. A818-6 hollow sphere cells were not tumorigenic in nude
mice (data not shown) and therefore a comparative in vivo example is lacking. However,
A818-6 cells supplied with a “mesenchymal cushion” consisting of fibroblasts attached to
this fibroblast-core with their basement membranes and developed “fibro spheres” in which
tumor cells showed the same orientation as found in hollow spheres (compare Fig. 24-26,
Results). These results suggest a more physical reason. Under suspension cell culture conditions
a ball-structure as a highly ordered structure exhibits the smallest entropy and may therefore
be preferred. Even a cell culture model derived from normal cells of the human nasopharynx
has been described to exhibit this ”inside-out” polarity (Boxberger et al., 1993). On the other
hand it is the apical membrane of a pancreatic epithelial cells that is in contact with a liquid
like the pancreatic juice and not the basolateral membrane. If the surrounding cell culture
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like the pancreatic juice and not the basolateral membrane. If the surrounding cell culture
medium is interpreted as the former pancreatic juice, A818-6 hollow sphere cells behave
normal when exposing their apical membranes towards the medium. Similar to Capan-1
(Levrat et al., 1988), A818-6 cell formed domes when grown to confluency as monolayer
cultures and hollow spheres may be seen as the three-dimensional equivalent to these domes.
Domes are a reflection of the presence of two media of different ionic concentrations separated
by a planar barrier of cells connected by tight junctions (Fanjul and Hollande, 1993). In
hollow spheres, differences in the concentration may be caused by the metabolic waste which
must be secreted into the lumen of the sphere due to their polarity and might further display a
reason for the limited life span of hollow spheres (Boxberger et al., 1993). Additionally, if
tight junctions between A818-6 hollow sphere cells are not leaky (Blackburn et al., 1988;
Rizzolo, 1997), the single layer of epithelial cells displays a functional barrier forcing the
cells to obtain nutrients completely from the apical side (Cereijido et al., 1989; Handler,
1989) which required the encapsulated cell culture medium as storage-pool for nutrition.
Next to β-catenin found associated to the basolateral membranes of A818-6 hollow sphere
cells, integrin-β−1 and integrin-β-5 were detected by immunocytochemistry at the basal
membranes of hollow sphere cells denoting the polarized phenotype (data not shown). Further
laminin being described as an important factor in the establishment of functional and structural
polarity (Ecay and Valentich, 1992; Moller et al., 1991) was observed at the basement
membranes of A818-6 hollow spheres (compare Fig. 26, Results) pointing to an essential role
of laminin in the development of A818-6 hollow spheres as well.
4.2.4 Proliferation of A818-6 cells
As an increase in proliferation is one of the most characteristic features associated with
malignant transformation (Koli and Keski-Oja, 1996; Tennenbaum et al., 1996; Muir, 1995),
it was demanding to analyze the differences in proliferation rates between A818-6 monolayer-
and hollow sphere cells. Although no DNA-profile was generated to investigate the distribution
of A818-6 cells in different phases of the cell cycle, a partial analysis of cell cycle distribution
was possible with the antibodies KiS5 and KiS2 (Frahm et al., 1999;Rudolph et al., 1998;
Heidebrecht et al., 1997; Rudolph et al., 1997; Heidebrecht et al., 1996). A massive decrease
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Heidebrecht et al., 1997; Rudolph et al., 1997; Heidebrecht et al., 1996). A massive decrease
in proliferation monitored by p27/Kip, cyclin B, Ki67 expression and telomerase assay during
hollow sphere development characterized A818-6 hollow sphere cells as normal duct epithelial
cells of the pancreas with the majority of cells being arrested in the G0-phase of the cell
cycle. From 31.5% of Ki67 positive cells in A818-6 hollow spheres only 2.2% were found in
the G2/S or M-phase of the cell cycle whereas approximately 24% were observed for monolayer
cells (compare Fig. 10, Results). This nearly 10-fold decrease is likely to be ascribed to the
re-stored ability of contact-inhibition in A818-6 hollow sphere cells underlined by findings
with p27/Kip in Western blot analysis (Chen et al., 1999).
Of particular interest in the context of proliferation in A818-6 cells is the downregulation of
the telomerase activity found in A818-6 hollow sphere cells. Human somatic cells have
essentially no detectable telomerase activity. Telomerase is linked to tumor genesis and is a
valuable marker for malignant growth (Morales et al., 1999; Krupp et al., 1997). It has been
shown that the ectopic expression of the telomerase catalytic subunit (hTERT) in combination
with two oncogenes (the simian virus 40 large-T oncoprotein and an oncogenic allele of
H-ras) results in direct tumorigenic conversion of normal human epithelial and fibroblast
cells (Hahn et al., 1999). Therefore, the regulation of the telomerase activity during hollow
sphere development may display an important functional aspect concerning the reversibility
of the A818-6 system (compare Results 3.1 Fig. 8 e and 3.3.2) and should be analyzed in
ongoing studies.
4.2.5 Expression of differentiation marker antigens
As bicarbonate secretion of ductal epithelial cells is an important physiological feature,
carbonic anhydrase II (CAII) is a marker for this type of cells (Nishimori et al., 1999).
Marker antigens for acinar cells are the enzymes lipase and amylase (Krishnamurthy and
Zamboni et al., 1996; Dayal, 1995). Consequently, CAII was detected in hollow sphere cells
by indirect immunofluorescence staining determining the ductal origin of A818-6 cells
underlined by negative staining results for lipase and amylase. Although widely accepted
carbonic anhydrase, lipase and amylase as marker antigens should be interpreted with caution
considering reports about transdifferentiation of former acinar cells into cells exhibiting
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considering reports about transdifferentiation of former acinar cells into cells exhibiting
characteristics of ductal cells (Schmid et al., 1999). However, in this study the focus was set
on clarifying the differences in the status of differentiation between two phenotypes of one
cell line and therefore markers revealing differences within the system were required. Factors
like p27/Kip, mucin-1, β-catenin, carbonic anhydrase, symplekin e.g. have been discussed
above.
A further group of marker antigens suitable to prove the different status in differentiation
between A818-6 monolayer and hollow spheres is displayed by members of the
carcinoembryonic antigen family. In particular CEA-180 is a known and frequently used
tumor marker detected in the serum of patients (Allum, 1990; Konomi et al., 1982). Former
studies showed  CEA was absent in normal tissue but detected in tumor tissue as assessed by
immunohistochemistry (Kim et al., 1990). In A818-6 hollow sphere cells CEA was only
detected in single cells by immunocytochemistry while most of the monolayer cells exhibited
a positive reaction with an antibody against CEA. Furthermore A818-6 hollow sphere cells
being positive for CEA exhibited an apical staining while monolayer cells were also stained
cyctosolically. These findings are in accordance with a theory saying that normal cells rapidly
release CEA into the lumen of the digestive tract due to their polarity and not into the
circulation like tumor cells (Kuroki et al., 1988). This theory is based on the observation that
CEA concentrations in normal sera are very low. Secretion analysis of supernatants from
A818-6 cells showed hollow sphere cells secreted only half of the amount of monolayer cells
which also denotes CEA as a marker for differentiation in this system (compare 3.4.6,
Results).
Next to mucin-1 another member of the mucin-family became interesting for the A818-6
system by means of different expression in monolayer- and hollow sphere cells. Leukosialin
(CD43) was originally detected in the hematopoietic system and described as a ”janus-headed”
molecule either showing a cell-adhesion function (Manjunath et al., 1993) or the direct
opposite by providing a repulsive barrier around cells (Zhang et al., 1997; Sanchez-Mateos et
al., 1995). It has been speculated that tumor cells even not being of hematopoietic origin
acquire the ability to express CD43 to passively repulse cells from the immune system
(Santamaria et al., 1996). To test this hypothesis immunofluorescence analyses were carried
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(Santamaria et al., 1996). To test this hypothesis immunofluorescence analyses were carried
out with an antibody against CD43, known to react positively with tumor tissue (Santamaria
et al., 1996). Only A818-6 monolayer cells were found to be positive for CD43 whereas
hollow spheres resembling a normal duct-like structure, were negative in this study (compare
3.4.2, Results). These results support the idea of CD43 as a passive defense of tumor cells
against attacks from the immune system and further suggest CD43 as an indirect differentiation
marker in the A818-6 system.
4.2.6 Influence of cytokines and growth factors 
Investigations on the effects of cytokines and growth factors were undertaken to obtain hints
for essential signal transduction pathways responsible for A818-6 hollow sphere development.
Investigations of the pathways regulating normal growth of epithelial cells have revealed the
existence of two major growth-factor signaling cascades required for proliferation. One pathway
is activated by IGF-1 or high insulin concentration. The other is triggered by EGF, TGF-α, or
members of the FGF family (Aaronson et al., 1990). The insulin-like growth factor pathway
was not addressed in this study. Structure and biological activity of EGF and TGF-α are quite
similar and both growth factors are ligands of the same receptor (epidermal growth factor
receptor, EGF-R) (Luetteke and Lee, 1990) being detected in A818-6 immunocytochemically
(data not shown). However, no visible stimulation on A818-6 hollow sphere development
was observed with both ligands. Many growth factors have been reported to be overexpressed
in pancreatic and other carcinomas including EGF and TGF-α (Aaronson et al., 1990; Friess
et al., 1996) suggesting that exogenously added higher amounts of already overexpressed
growth factors exhibit no further stimulation due to the high present concentrations (Karnes
et al., 1992). Growth stimulation of A818-6 cells was only observed with exogenously added
bFGF a factor which also belongs to the pathway triggered by EGF and TGF-α in normal
epithelial cells (Aaronson et al., 1990). Pancreatic cancers overexpress basic FGF (bFGF) and
the type I FGF receptor (FGFR-1), and overexpression of bFGF has been correlated with
decreased patient survival (Wagner et al., 1998). A818-6 hollow sphere cells were growth
stimulated without disrupting or altering the highly differentiated hollow sphere structure
pointing to a bFGF function in differentiation as observed during human embryogenesis
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pointing to a bFGF function in differentiation as observed during human embryogenesis
(Tienari et al., 1995) or fibre cell differentiation of the human lens (Leenders et al., 1997). On
the other hand, Hirai and co-workers were able to show for HGF/SF that is was not the
growth factor itself being responsible for lumenal differentiation in mammary epithelial cells.
In fact HGF/SF and other growth factors provided the proliferation stimulus necessary for
differentiation, while epimorphin exhibited the morphoregulatory function (Hirai et al., 1998).
Interferon-γ has been described to cause cell death in the human epidermoid carcinoma cell
line A431 either grown in conventional monolayer culture or in three-dimensional spheroids
(Ridge et al., 1991; Chang et al., 1987) as a cause of acceleration of terminal differentiation.
These observations are similar to those obtained with exogenously added IFN-γ in cultures
with A818-6 cells. Further IFN-γ has been described to exhibit apoptosis inducing capabilities
like tumor necrosis factor alpha (TNF-α) (Munker and Andreeff, 1996). Like IFN-γ, TNF-α
also induced cell death in A818-6 cultures. TNF-α is multipotent molecule exhibiting many
functions in either health or disease. Studies on the biological effects of TNF-α carried out in
tissue culture, organ perfusion systems, animals, human volunteers and cancer patients suggest
a general consensus for TNF-α as a key mediator of inflammation and the mammalian hosts
response to injury or invasion by microbes, parasites or neoplasia (Tracey, 1994). Yet, the
status of TNF-α receptors p55 and p75 (Kalthoff et al., 1993a) has not been specified in
A818-6 cells and therefore it is difficult to interpret TNF-α effects. Eventually an effect is
mediated through the induction of IFN-γ or TGF-β by TNF-α (Tracey, 1994), whereas
further results from experiments with TGF-β suggest a different mechanism than for IFN-γ.
TGF-β was found to inhibit A818-6 hollow sphere development but had no effect on mature
hollow spheres or monolayer cells (compare 3.5, Results). New experiments revealed an
upregulation of the cell cycle inhibitor p21/Cip after addition of recombinant TGF-β . The
same result was observed after transduction of A818-6 cells with a constitutive active TGF-β
I receptor. In these cells A818-6 hollow sphere development was massively slowed down.
These findings are in accordance with the general ability of TGF-β to induce cell cycle
inhibitory proteins, in particular p21 and the role of TGF-β1 in contact inhibition (Lloyd et
al., 1999; Miyazaki et al., 1998).
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4.2.7 Mesenchymal co-culture
Although effects of factors like EGF, TGF-α and in particular HGF/SF on the morphogenesis
of epithelial cells have been reported (Birchmeier et al., 1997; Brinkmann et al., 1995; Barton
et al., 1991), no effects on either hollow sphere development or mature hollow spheres were
observed. Therefore co-culture experiments have been undertaken to unravel the importance
of the direct presence of mesenchymal cells to mediate effects either by direct cell-cell
contact or by secreting soluble factors into the cell culture medium. Since it has been known
for a long time the mesenchymal influence is a prerequisite for a proper development of the
human pancreas (Polak et al., 2000; Ramalho-Santos et al., 2000; LeBras et al., 1998), the
major importance of the mesenchyme in carcinogenesis is more and more recognized (Chung,
1995; Condon and Bosland, 1999; Hirai, 1993). A818-6 cells were stimulated by the direct
presence of either organ-derived fibroblasts or skin-derived fibroblasts. Three experimental
set ups were chosen to co-culture A818-6 cells with fibroblasts (compare 3.6, Results).
Similar results for both fibroblast types were obtained after either trypsinated A818-6 cells or
pre-mature hollow spheres were seeded on top of confluent fibroblast monolayers. Both
fibroblast types supported the invasiveness of A818-6 monolayer cells as shown by the
development of invasive tumor cell plaques within the confluent fibroblast monolayers or the
growth of pre-mature hollow spheres into larger spheres of approximately equal size and
shape (compare 3.6.1, Results). Growth stimulating effects of fibroblasts on epithelial cells
have been contributed to mesenchmally derived growth factors like HGF/SF, KGF, EGF,
VEGF e.g. secreted by the fibroblasts and acting via paracrine mechanisms (Zeigler et al.,
1996; Hlatky et al., 1994; Nusrat et al., 1994). Subsequently conditioned medium of fibroblasts
was tested for the ability to replace the direct presence of fibroblasts in the A818-6 co-culture
experiments.  Some stimulatory effect was observed when A818-6 hollow spheres were
subjected to fibroblast-conditioned medium (without bFGF and insulin) but this stimulation
was less effective than the effect with fibroblasts present in culture. This finding is surprising
because pre-mature hollow spheres were stimulated when seeded onto confluent fibroblast
monolayer cultures. Due to their ”ball-like” structure direct contact to mesenchymal cells was
limited to few A818-6 hollow sphere cells at a given time or by ”rolling” over the fibroblasts.
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limited to few A818-6 hollow sphere cells at a given time or by ”rolling” over the fibroblasts.
Unless culture plates remained unmoved in the incubator for most of the time it is unlikely
that hollow spheres have discovered a method of ”self-movement” during the time they were
not investigated. However, experiments with conditioned media have been found to be critical
(Otonkoski et al., 1996). It further has been shown to be of crucial importance for the
observed effects whether normal fibroblasts from the same organ, tumor-derived fibroblasts
or fibroblasts from a different organ including their corresponding supernatants were taken
for the experiments (Rossi et al., 2000; Brouty-Boye et al., 1994). These observations made
by others support the results obtained after co-culturing trypsinated A818-6 cell with fibroblasts
at a ratio of 1:1. Here differences between pancreas- and skin-derived fibroblasts were detected
(compare 3.6.2, Results). Taken together, A818-6 cells were stimulated by fibroblast co-cultures.
The ”malignant” monolayer-phenotype showed an enhanced invasiveness by means of a
higher proliferation rate of the cells growing as invasive plaques in confluent fibroblast
monolayer cultures, while A818-6 hollow sphere cells were growth stimulated without
disturbance of the highly differentiated hollow sphere phenotype. The fact that both cell types
induce each other makes it difficult to speculate whether the secreted factors of the ”benign”
hollow sphere phenotype induce fibroblasts to secrete differentiation stimulating factors or
whether the secreted mesenchymal factors were the same under conditions used in this study
and the receptor status of A818-6 cells changed with respect to the differentiation status of
monolayer- or hollow sphere cells. Therefore it is useful to determine the expression status of
interesting factors independently in both compartments and than perform combining
experiments. Such a procedure was performed for one mesenchymally derived factor called
epimorphin.
4.2.8 The role of epimorphin in the A818-6 system
Recently epimorphin has emerged as an important morphoregulator derived from mesenchymal
cells being also found in epithelial cells. Epimorphin has further been found to be responsible
for the branching morphogenesis and lumen formation in breast epithelial cells of the mouse
and is known to be a leading factor in the reconstitution of the liver (Hirai et al., 1998;
Watanabe et al., 1998). This study shows that certain isoforms of epimorphin are important
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Watanabe et al., 1998). This study shows that certain isoforms of epimorphin are important
factors for the development of lumenal structures of pancreatic duct epithelial cells. As
described for hair follicle growth and lung epithelial tubular formation (Hirai et al., 1992), the
antibody MC-1 was found to be a potential inhibitor of A818-6 hollow sphere development.
In accordance with previous work on mammary epithelial cell development (Hirai et al.,
1998), no effects on hollow sphere development by using a neutralizing antibody against
HGF were found. All reported isoforms of epimorphin (34kDa- and 31kDa-monomers) as
well as the dimeric and tetrameric form were detected in fibroblasts whereas the 150kDa-tetramer
of epimorphin was not detectable in lysates of A818-6 cells as assessed by Western blot
analysis. Interestingly, a strict correlation between the ability of lumen-formation of pancreatic
duct cells and the expression pattern of the 34kDa- and 31kDa-isoforms of epimorphin in cell
lysates was observed. So far it is believed the extracellular and membrane-associated tetrameric
complex (150kDA) represent the morphoregulatory form of epimorphin (Zhang et al., 1999;
Hirai et al., 1998). In this study all monomeric isoforms and the dimeric form of epimorphin
were detected in the supernatants of A818-6 cells and fibroblasts but no tetrameric form of
150kDa being restricted to fibroblast extracts. As immunoprecipitation data analyzing
conditioned medium from A818-6 hollow spheres without co-cultivated fibroblasts revealed
only the 34kDa- and 31kDa-isoforms which are able to either form homo- or heterodimeric
complexes, morphogenic activity is attributed to these smaller forms. Interestingly, at least
one 31kDa-isoform of epimorphin was reported to lack a putative membrane spanning domain
further denoting a soluble character of at least one epimorphin-isoform (Hirai et al., 1998).
Additionally, dimer-formation should only appear in case of undegraded monomers of
epimorphin pointing to an ectodomain of epimorphin with functional interaction sites (Gilboa
et al., 1998; Miller et al., 1995). The different affinities of the monoclonal antibody MC-1
and the affinity purified polyclonal antibody for either native or denatured forms of epimorphin
are explained by the history of their production (Hirai et al., 1998; Hirai et al., 1992). This
study was able to prove the presence of epimorphin and soluble epimorphin in particular in
human pancreatic adenocarcinoma cells. Moreover, for the first time a functional effect of
epimorphin on human epithelial cells exhibiting duct-like development was shown. Whether
soluble epimorphin displays the active form of this competent morphoregulator also in other
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soluble epimorphin displays the active form of this competent morphoregulator also in other
tissues and whether quantitative differences in the ratio between monomeric and dimeric
forms, as they are shown in Fig. 30 and 31, are of functional relevance need be addressed in
further studies.
4.3 Conclusions
So far, most systems which are regarded as reflecting a situation comparable to normal
tissues required an artificial three-dimensional environment. Some systems depended on
exogenously added components like growth factors or other cytokines. The A818-6 hollow
sphere system analyzed in this thesis developed spontaneously upon one single stimulus; the
prevention from adherence. Although not being the first system which was described to
exhibit the ability of lumenal differentiation under three-dimensional conditions, the A818-6
system is the only system derived from cells of the human exocrine pancreas developing
single layered epithelial, lumenal structures. Furthermore, it recovers a functional contact
inhibition as indicated by a dramatic decrease in proliferation during and after hollow-sphere
formation. The polarized expression of members of the CEA-family, BGP and NCA as well
as β-catenin or mucin-1 displays exactly the situation found in normal pancreatic tissue.
Polarity is underlined by secretion of CEA 180 into the supernatant of hollow sphere cultures
or the development of microvilli on apical membranes. When hollow spheres are disrupted or
trypsinated and seeded into normal tissue culture flasks, cells grow as monolayer culture.
When these cells are trypsinated again and seeded under three-dimensional growth conditions,
hollow sphere formation takes place. This system is able to differentiate and de-differentiate
in a reversible manner. Keeping in mind that A818-6 cells are derived from pancreatic
adenocarcinoma and bear distinct genetic alterations these cells must ”walk on a thin line”
between malign and benign taken hollow sphere development as a hallmark for a benign
phenotype. Yet unknown ”major-switches” responsible for lumenal differentiation are activated
and deactivated in a reversible manner suggesting the A818-6 system as an interesting tool to
unravel questions associated with the development of cell-cell contacts or the loss of the
latter as observed during metastasis. In this thesis epimorphin has been found to present a
potent candidate for such a ”major switch” due to its dramatic influence on A818-6 hollow
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potent candidate for such a ”major switch” due to its dramatic influence on A818-6 hollow
sphere development and should be analyzed in more detail in ongoing studies. The reversibility
combined with a quick access to high amounts of hollows spheres grown under standardized
conditions display the practical advantage of this system enabling a researcher to confirm and
extend the results without the limit of material resources as often associated to experiments
carried out with normal tissue or primary cell cultures.
4.4 Future directions
If the general question about the future development of biological research is posed, the
statements may be summarized as follows: Molecular biological techniques will be further
improved allowing high throughput analyses for proteins like they are possible of nucleic
acids today. Due to the increasing amounts of new sequences arising from the human genome
project displaying potential genes of therapeutic relevance, a further focus will be put on
bioinformatics in the future. Bioinformatics allow to navigate through the jungle of new
sequences and to determine potential candidate genes by performing in silico experiments
like virtual Northern blots following sequence alignments. However, beside these technical
improvements a third field was lined out as important for future development. Biological
read-out systems are essential to prove the biological function of sequences found by either
virtual or classical methods for gene-hunting.
The unique three-dimensional shape of A818-6 hollow spheres displays a read-out criterion
which is easy to document and can help to unravel gene functions being associated with
cell-adhesion, cell cycle control, cell polarity, secretion of ductal epithelial cells, proliferation,
contact inhibition and many more. Results may be either obtained by treating A818-6 cells
with potential therapeutic agents or by transducing A818-6 monolayer cells with a gene of
interest and subjecting these cells to three-dimensional growth conditions. Primary experiments
have been set up to use hollow spheres as a model for functional epithelial barrier. Administration
of infected gall or pancreatic juice from the bile duct may help to understand more about the
mechanisms of acute pancreatitis since it has been described that bacterial invasion is associated
with destruction of the tight junctions complexes (Arendt, 1991). As these experiments with
infected juices were carried out in cats, the A818-6 system may be used to reduce animal
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infected juices were carried out in cats, the A818-6 system may be used to reduce animal
experiments in the future. Further experimental set up will use the barrier function to investigate
the capability of phagocytosis in A818-6 cells. Preliminary results show different behavior of
A818-6 hollow sphere cells in comparison to monolayer cells when they are fed with small
fluorescing particles. The malignant monolayer took up particles quickly and in high amounts
while hollow sphere cells phagocytosed only a few. Results from these experiments might
help to develop methods for retrograde administration of agents coupled to particels which
are phagocytosed by cancer cells of ductal origin without harming the normal cells.
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5 Summary
Standard cell culture conditions  must be considered as artificial especially with respect to the
environment cancer cells are grown in. While tumors in patients exhibit a three-dimensional
shape isolated cells are forced to grow as monolayer cultures two-dimensionally. Early
experiments of Holtfreter and co-workers (Holtfreter, 1947; Holtfreter, 1944) showed the
environment cells are grown in has a major impact on their behavior. Inch and co-workers
(Inch et al., 1970) started experiments using compact aggregates of tumor cells (spheroids)
for radiotherapy experiments opening a field of ”in vitro mini-tumor” research using spheroids
leading to relevant results in cancer research, in particular, analyses on tumor sizes (necrosis
in tumors larger than 0.5- 0.9 mm in  diameter) or angiogenesis.
This thesis characterizes a subclone of the pancreatic carcinoma cell line A818 called A818-6,
developing hollow spheres under three-dimensional growth conditions. Hollow spheres consist
of a single layer of 50-200 epithelial cells surrounding an inner lumen. In contrast, to A818-6,
a subclone called A818-4 and many other cell lines tested formed compact spheroids as the
only three-dimensional phenotype. A dramatically reduced proliferation rate compared to the
corresponding monolayer was observed in hollow spheres as assessed by immunocytological
staining against proliferation associated antigens like Ki67, p100 and p27/Kip or by TRAP-assay
measuring telomerase activity. Hollow spheres developed in FCS-containing RPMI-1640-
medium without additionally added cytokines. A818-6 hollow sphere formation and integrity
was influenced by Interferon-γ, TGF-β, bFGF and TNF-α lead to cell death. Exogenously
added HGF neither showed an effect on hollow sphere formation nor on the integrity of
completely developed hollow spheres. Moreover, no changes were observed when cells were
treated with a neutralizing antibody for HGF. Interestingly, hollow spheres showed intensive
immunoreactivity for both, the HGF-receptor (c-met) and its ligand HGF. Immunostaining
against BGP, NCA95, mucin-1 and β-catenin revealed a polar organization of hollow spheres
further underlined by ultrastructural analyses showing tight junction formation at apical
membranes of hollow sphere cells which were additionally covered with highly developed
microvilli. Immunhistochemically, hollow spheres were negative for CEA-180. Interestingly,
released CEA was found in the supernatant. Due to their polarity, hollow sphere cells must
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released CEA was found in the supernatant. Due to their polarity, hollow sphere cells must
secrete CEA apically which resembles the normal situation in gastrointestinal epithelial tissues.
Mechanically disrupted hollow spheres not only attached but also grew as monolayer with the
same doubling time as the founder cells. Co-culture of A818-6 cells with fibroblasts stimulated
the development of hollow sphere structures in general and increased differentiation in 5-6
day old hollow spheres. Epimorphin was recently described as a mesenchymal factor modulating
morphogenesis of murine mammary ducts, skin, liver and lung in vitro. Soluble 34kDa- and
31kDa-isoforms of epimorphin were detected in the culture supernatant of A818-6 cells. In
lysates of A818-6 cells the 34kDa-, 31 kDa-isoforms and the dimers were detected. Lysates
of  fibroblasts additionally showed a 150kDa-tetramer of epimorphin. The tetrameric form
was only detected in fibroblast lysates. A neutralizing monoclonal antibody against epimorphin
(MC-1) blocked the development of hollow sphere structures from A818-6 cells efficiently.
Cells treated with MC-1 were maintained in a developmental stage characteristic for days 2-3
of normal hollow sphere development. In this novel system for human duct-like differentiation
of pancreatic epithelial cells strong evidence for an autocrine function of epimorphin as a
major mediator for morphogenesis is provided. This is the first study showing a functional
effect of epimorphin in cells of human origin.
Taken together, A818-6 hollow spheres resemble normally differentiated duct-like structures
and will serve as an excellent model to study differentiation of  pancreatic epithelial cells on
morphological and molecular basis.
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6 Zusammenfassung
Standard Zellkulturbedingungen müssen besonders im Hinblick auf die Umgebung, in der
Krebszellen gezüchtet werden, als artifiziell angesehen werden. Tumore im Patienten sind
dreidimensionale Gebilde, während man isolierte Krebszellen in Kulturflaschen zwingt, unter
zweidimensionalen Bedingungen zu wachsen. Frühe Experimente von Holtfreter und
Mitarbeitern (Holtfreter, 1947; Holtfreter, 1944) zeigten, dass die Form der Zellkultur
maßgeblichen Einfluss auf das Verhalten von Zellen hat. Inch und Mitarbeiter (Inch et al.,
1970) begannen,  kompakte Tumorzellaggregate (Sphäroide) mit Radiotherapie zu behandeln,
und eröffneten damit ein neues Feld der ”in vitro-Minitumor”-Forschung, welches relevante
Ergebnisse besonders in den Bereichen Tumorgröße (Nekrose in Tumoren, die größer als 0,5-
0,9mm im Durchmesser werden) und Angiogenese hervorbrachte. Diese Dissertation
charakterisiert einen Subklon der Pankreasadenokarzinomzelllinie A818, die A818-6 Zellen.
Dieser entwickelt unter dreidimensionalen Kulturbedingungen ”hollow spheres”. ”Hollow
spheres” sind einschichtige Epithelhohlkugeln die aus 50 bis 200 Epithelzellen bestehen,
welche ein ein inneres Lumen umschließen. Im Gegensatz zu A818-6 erzeugen ein anderer
Subklon (A818-4) und viele andere getestete Zelllinien nur kompakte Sphäroide als einzige
dreidimensionale Wachstumsform.
Ein dramatischer Rückgang der Proliferationsrate wurde während der Entwicklung von A818-6
hollow spheres beobachtet, gemessen an dem Vergleich der Expression von proliferations-
assoziierten Antigenen wie Ki67, p100, p27/Kip oder der relativen Telomeraseaktivität in
A818-6 ”monolayer”- oder ”hollow sphere Zellen”. Die ”hollow sphere” Entwicklung vollzog
sich in RPMI1640-Medium ohne Zusatz von Zytokinen oder Wachstumsfaktoren, konnte
aber durch exogene Zugabe bestimmter Faktoren wie Interferon-γ, TGF-β und bFGF beeinflusst
werden. Die Zugabe von TNF-α führte zur Apoptose. Keine Veränderungen wurden mit
rekombinantem HGF oder einem HGF-neutralisierenden Antikörper festgestellt.
Interessanterweise exprimierten A818-6 Zellen sowohl HGF als auch seinen Rezeptor c-met.
Immunzytologische Experimente mit Färbungen gegen Antigene wie BGP, NCA95, Muzin-1
oder β-catenin offenbarten die strikt polare Orientierung der A818-6 Zellen im ”hollow
sphere”. Diese Polarität konnte desweiteren durch elektronenmikroskopische Analysen
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sphere”. Diese Polarität konnte desweiteren durch elektronenmikroskopische Analysen
untermauert werden. Diese zeigten ”tight junctions” zwischen den apikalen Membranen von
”hollow sphere” Zellen, welche zusätzlich noch hoch entwickelte Mikrovillistrukturen trugen.
Immunzytochemisch waren ”hollow spheres” negativ für CEA-180. Interessanterweise wurde
sezerniertes CEA-180 aber im Zellkulturüberstand von ”hollow spheres” gefunden.
Entsprechend ihrer Polarität mit den apikalen Membranen Richtung Zellkulturmedium muss
CEA apikal sezerniert werden. Dieses entspricht der Situation, welche im normalen
gastrointestinalen Gewebe gefunden wird. Zellen von mechanisch zerstörten ”hollow spheres”
wuchsen in normalen Kulturflaschen an und bildeten neue Monolayer-Kulturen, die den
Ausgangszellen entsprachen. Co-Kultur Experimente mit A818-6 Zellen und Fibroblasten
stimulierten die Entwicklung der ”hollow spheres” im allgemeinen und steigerte den
Differenzierungsgrad von 5-6 Tage alten ”hollow spheres”. Epimorphin wurde kürzlich als
mesenchymaler Faktor beschrieben, welcher massiven Einfluss auf die Morphogenese von
murinen Brustdrüsengängen, der Haut, Leber und Lunge hat. Lösliche 34kDa- und 31kDa-
Isoformen von Epimorphin wurden im Zellkulturüberstand von A818-6 ”hollow spheres”
gefunden. In Proteinlysaten von A818-6 Zellen fanden sich die 34kDa- und 31kDa-Isoform
sowie eine dimere Form. Proteinlysate aus Fibroblasten zeigten zusätzlich noch eine tetramere
Form von 150 kDa, welche aber nur in Fibroblasten gefunden wurde. Ein epimorphin-
neutralisierender Antikörper (MC-1) war in der Lage, die Enwicklung der ”hollow spheres”
zu unterbinden, wobei die Zellen nicht getötet wurden, sondern auf Entwicklungsstufen der
Tage 2-3 wie unter unbehandelten Bedingungen festgehalten wurden. Somit konnte ein
autokriner Mechanismus für Epimorphin in der Differenzierung von Pankreas-
adenokarzinomzellen zu gangähnlichen Strukturen gezeigt werden.
Dieses ist die erste Studie, welche einen morphoregulatorischen Effekt von Epimorphin in
menschlichen Zellen zeigt.
Zusammengefasst verhalten sich A818-6 ”hollow sphere” Zellen in grundlegender Hinsicht
wie normale Pankreasgangepithelzellen und eignen sich deshalb besonders als Modell zum
weiteren Studium von Differenzierungvorgängen in normalen Pankreasgangepithelzellen.
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Raw data proliferation
counted cells positive cells counted cells negative cells
298 19 212 197
248 15 308 286
256 23 304 283
802 57 824 766
267,333333 19 274,666667 255,333333
26,8576494 4 54,3077649 50,5404129
KiS2-staining
A818-6 hollow spheres
average
standard deviation
KiS2-staining
A818-6 monolayer
counted cells positive cells counted cells negative cells
183 45 192 145
167 41 168 127
201 49 188 142
551 135 548 414
183,666667 45 182,666667 138
17,0098011 4 12,858201 9,64365076
average
standard deviation
KiS5-staining
A818-6 hollow spheres
counted cells positive cells counted cells negative cells
278 88 254 174
312 98 268 184
323 102 317 217
913 288 839 575
304,333333 96 279,666667 191,666667
23,4591844 7,21110255 33,0807094 22,5018518
average
standard deviation
705 670 772 39
235 223,333333 257,333333 13
21,6564078 20,1328918 29,7040962 1,73205081
238 226 281 14
212 202 267 14
counted cells positive cells counted cells negative cells
255 242 224 11
KiS5-staining
A818-6 monolayer
average
standard deviation
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PCR-Primer to human epimorphin
EPIMOR-SENSE
5’-TACCAAGACCTTTGGTGAAGGG-3’
EPIMOR-ASENSE
5’-AAGCTATGGGAGCATAAGCAGC-3’
Primers used for the RNaseP template in telomerase-assay (TRAP-assay)
F286: 5’-GCTTGCCAATCCGTCGAGCAGAGTTCGGGATGGGCCGCTTGAGGC-3’
R376: 5’-GTGCCCTTACCCTTACCCTTACCCTAACGCCTCCGGGACGAGGCGTAAG-3’
The primers inculde the sequences for TS and CX-ext respectively (underlined).
Telomerase-assay raw data
32,354 4,815
20,359 7,434
19,429 0,845
17,571 1,69
10,728 1,858
20,0882 3,3284
7,02 2,44
average
standard deviation
Monolayer Spheres
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Abbreviations
APC Gene product of adenomatous poliposis coli gene
APS Ammonium Persulfate
BGP Biliary Glycoprotien
CAII Carbonic Anhydrase type II
Cdk´s Cyclin-dependend Kinases
cDNA Complementary Desoxyribonucleic Acid
CMV Cytomegalovirus
DMSO Dimethyl Sulfoxid
DNA Desoxribonucleic Acid
EGF Epidermal Growth Factor
EGFP Enhanced Green Fluorescent Protein
ELISA Enzyme-Linked Immuno-Sorbent Assay
FCS Fetal Calf Serum
G418 Aminoglycoside antibiotic geneticin
gag Retroviral structural gene encoding the group antigen (capsid, nucleocapsid,
matrix, protase proteins)
h hour
HBSS Hank´s Balanced Salt Solution
HGF/SF Hepatocyte Growth Factor/Scatter Factor
HRP Horeseradish Peroxidase
IGF Insulin-like Growth Factor
ITAS Internal amplification standard
MLV Murine Leukemia Virus, moloney strain
MOI Multiplicity of infection
Muc-1 Human Mucin-1
NCA Nonspecific Crossreacting Antigen
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NCA Nonspecific Crossreacting Antigen
PBS Phosphate Buffered Saline
pol Retroviral structural gene encoding reverse transcriptase including polymerase
RNase H and integrase
PDVF Polyvinillidene diffluoride
RNA Ribonucleic Acid
RT Room Temperature
SCID-bg Severe Combined Immunedeficiency Defect-beige
SDS Sodiumdodecyl Sulfate
TEMED N,N,N,N-Tetramethylethylenediamine
TGF´s Transforming Growth Factors
TNF´s Tumor Necrosis Factors
TRAIL TNF-Related Apoptosis Inducing Ligand
VEGF Vascular Endothelial Growth Factor
VSV-G Vesicular Stomatitis Virus Glycoprotein
All other abbreviations are explained directly in the text.
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